Professional Documents
Culture Documents
1 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
CORPORATE INFORMATION
2 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
NOTICE
Notice is hereby given that the 30th Annual General Meeting of the members of Nexus
Surgical and Medicare Limited (Formerly known as Nexus Commodities and Technologies
Limited) will be held on Wednesday, 29th September, 2021 at 04:00 p.m. through Video
Conferencing (“VC Other Audio Visual Means (“OAVM
business:
ORDINARY BUSINESS:
1. To receive, consider and adopt the Audited Financial Statements of the Company for the
financial year ended 31st March, 2021 together with the Report of Directors and Auditors
thereon.
2. To appoint a Director in place of Mr. Rupesh Roongta (holding DIN 02576510), who
retires by rotation, and being eligible, offers himself for re-appointment.
SPECIAL BUSINESS:
To consider and if thought fit, to pass with or without modification, the following
resolution as an Ordinary Resolution:
“RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 and any other
applicable provisions, if any, of the Companies Act, 2013 (“the Act”) and the Companies
(Appointment and Qualification of Directors) Rules, 2014 (including any statutory
modifications or re-enactment thereof for the time being in force) read with Schedule IV
to the Act and Regulation 16(1)(b) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”),
Ms. Neha Kailash Bhageria (holding DIN 09217784), who was appointed as an
Additional Director of the Company by the Board of Directors with effect from 30 th June,
2021 and whose term of office expires at the Annual General Meeting and who has
submitted a declaration that she meets the criteria for independence as provided in the Act
and Listing Regulations, be and is hereby appointed as an Independent Woman Non-
Executive Director of the Company with effect from September 29, 2021, to hold office
for a term of five consecutive years i.e. up to September 28, 2026.
RESOLVED FURTHER THAT the Board of Directors and Company Secretary of the
Company be and are hereby authorized to do all such acts, deeds, matters and things and
to take all such steps as may be necessary, proper or expedient to give effect to this
resolution.”
4. Shifting of Registered Office of the Company from one city to another city within
the same State:
To consider and if thought fit, to pass with or without modification, the following
resolution as a Special Resolution:
3 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
“RESOLVED THAT pursuant to the provisions of Section 12 and any other applicable
provisions, if any, of the Companies Act, 2013 (“the Act”) and the Companies
(Incorporation) Rules, 2014 (including any statutory modifications or re-enactment(s)
thereof for the time being in force) and the provisions of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“Listing Regulations”) and subject to approval of the Registrar of Companies, the
consent of the members of the Company be and is hereby accorded to shift the registered
office of the Company from “Thane” to “Palghar” in the State of Maharashtra.
RESOLVED FURTHER THAT the Board of Directors and Company Secretary of the
Company be and are hereby authorized to do all such acts, deeds, matters and things and
to take all such steps as may be necessary, proper or expedient to give effect to this
resolution.”
NOTES:
2. Pursuant to the provisions of the Act, a member entitled to attend and vote at the
meeting is entitled to appoint a proxy to attend and vote on his/her behalf and the proxy
need not be a member of the Company. Since this AGM is being held pursuant to the
MCA Circulars through VC / OAVM, physical attendance of members has been
dispensed with. Accordingly, the facility for appointment of proxies by the members
will not be available for the AGM and hence the Proxy Form, Attendance Slip and
Route Map are not annexed to this Notice.
4 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
4. The attendance of members attending the AGM through VC / OAVM will be counted
for the purpose of ascertaining the quorum under Section 103 of Companies Act, 2013.
5. Explanatory Statement under Section 102 of the Companies Act, 2013 in respect of
special business is annexed hereto and forms part of the Notice.
6. Pursuant to Regulation 36(3) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 and the Secretarial
Standards on General Meetings (SS-2), the information regarding the Directors
proposed to be appointed/ reappointed at the Annual General Meeting is given in the
Annexure to this Notice.
7. The Register of Members and the Share Transfer Books of the Company will be closed
from September 23, 2021 to September 29, 2021 (both days inclusive).
8. In accordance with, the circulars issued by MCA and Securities and Exchange Board of
India ('SEBI'), owing to the difficulties involved in dispatching of physical copies of the
Annual Report of the Company and the Notice of AGM, the same are being sent in
electronic mode to Members whose e-mail address is registered with the Company or
the Depository Participants (DP).
9. Members who have not registered their e-mail addresses so far are requested to register
the same with their DPs in case the shares are held by them in electronic form and with
the Registrar & Share Transfer Agent in case the shares are held by them in physical
form for receiving all communication including Annual Report, Notices, etc. from the
Company electronically.
10. Members are requested to furnish their bank account details, change of address and all
other required details to the Registrar & Share Transfer Agent in respect of shares if
held in physical form. In case of shares held in electronic form, these details should be
furnished to the respective Depository Participants (DPs).
11. The Securities and Exchange Board of India (“SEBI”) has mandated the submission of
Permanent Account Number (“PAN”) by every participant in the securities market.
Members holding shares in electronic form are therefore, requested to submit their PAN
card numbers / copies of PAN card to their depository participants with whom they are
maintaining their demat accounts. Members holding shares in physical form can submit
their PAN details to the Company/Registrar and Share Transfer Agent, M/s. Purva
Sharegistry (India) Private Limited.
12. The Securities and Exchange Board of India (“SEBI”) has mandated that transfer of
securities would be carried out in dematerialized form only w.e.f. 5th December, 2018.
In view of the same and to avail various benefits of dematerialization, members are
requested to dematerialize shares held by them in physical form
5 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
13. Members can avail of the facility of nomination in respect of shares held by them in
physical form pursuant to the provisions of Section 72 of the Companies Act, 2013.
Members desiring to avail of this facility may send their nomination in the prescribed
Form No. SH-13 duly filled in to M/s. Purva Sharegistry (India) Private Limited at the
Registered Office of the Company. Members holding shares in electronic form may
contact their respective Depository Participants for availing this facility.
14. Members may please note that Notice of the 30th Annual General Meeting and Annual
Report for the year ended 31st March, 2021 will be available on the Company’s website
www.nexusmed.co.in for their download. The Notice can also be accessed from the
website of BSE Limited at www.bseindia.com and the website of CDSL (agency for
providing the Remote e-Voting facility and e-voting system during the AGM) i.e.
www.evotingindia.com. For any communication, the members may also send requests
at Company’s email id: nexuscomm92@gmail.com.
15. Pursuant to the provisions of Section 108 of the Companies Act, 2013 read with Rule
20 of the Companies (Management and Administration) Rules 2014 as amended from
time to time and Regulation 44 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, the Company is
providing facility of remote e-voting to its Members in respect of the business to be
transacted at the AGM. For this purpose, the Company has entered into an agreement
with Central Depository Services (India) Limited (CDSL) for facilitating voting through
electronic means, as the authorized e-Voting’s agency. The facility of casting votes by a
member using remote e-voting as well as the e-voting system on the date of the AGM
will be provided by CDSL.
16. The Members can join the AGM in the VC / OAVM mode 15 minutes before and after
the scheduled time of the commencement of the meeting by following the procedure
mentioned in the Notice. The facility of participation at the AGM through VC / OAVM
will be made available to atleast 1,000 members on first come first served basis. This
will not include large shareholders (Shareholders holding 2% or more shareholding),
Promoters, Institutional Investors, Directors, Key Managerial Personnel, Chairpersons
of the Audit Committee, Nomination and Remuneration Committee and Stakeholders
Relationship Committee, Auditors etc. who are allowed to attend the AGM without
restriction on account of first come first served basis.
17. M/s. Nitesh Chaudhary & Associates, Practicing Company Secretary, Mumbai, has
been appointed as the Scrutinizer to scrutinize the remote e-voting process and e-voting
at the AGM in a fair and transparent manner.
18. Instructions for shareholders for registration of E-mail Ids and Bank Details:
6 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
The members are requested to provide details such as Name, DPID, Client ID/
PAN, mobile number and e-mail id. In case of any query, a member may send an
e-mail to RTA at support@purvashare.com. On submission of the shareholders
details an OTP will be received by the shareholder which needs to be entered in
the link for verification.
19. Instructions for shareholders for remote e-voting and joining the meeting are as
under:
(i) The remote e-voting period begins on <September 26, 2021 (09.00 a.m.)> and
ends on <September 28, 2021 (05.00 p.m.)>. During this period, members of the
Company, holding shares either in physical form or in dematerialized form, as on
the cut-off date (record date) of <September 22, 2021>, may cast their vote
electronically. The remote e-voting module shall be disabled by CDSL for voting
thereafter.
7 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
(ii) Shareholders who have already voted prior to the meeting date would not be
entitled to vote at the meeting venue.
Pursuant to abovesaid SEBI Circular, Login method for e-Voting and joining
virtual meetings for Individual shareholders holding securities in Demat mode
CDSL/NSDL is given below:
8 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Important note: Members who are unable to retrieve User ID/ Password are advised to
use Forget User ID and Forget Password option available at abovementioned website.
Helpdesk for Individual Shareholders holding securities in demat mode for any
technical issues related to login through Depository i.e. CDSL and NSDL
Login type Helpdesk details
Individual Shareholders holding Members facing any technical issue in login can contact
securities in Demat mode with CDSL helpdesk by sending a request at
CDSL helpdesk.evoting@cdslindia.com or contact at 022-
23058738 and 22-23058542-43.
Individual Shareholders holding Members facing any technical issue in login can contact
securities in Demat mode with NSDL helpdesk by sending a request at evoting@nsdl.co.in
NSDL or call at toll free no.: 1800 1020 990 and 1800 22 44 30
(iv) Login method for e-Voting and joining the meeting for Physical shareholders and
shareholders other than individual holding in Demat form:
9 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
6. If you are a first time user follow the steps given below:
8. Shareholders holding shares in physical form will then reach directly the
Company selection screen. However, members holding shares in demat form
will now reach ‘Password Creation’ menu wherein they are required to
mandatorily enter their login password in the new password field. Kindly
note that this password is to be also used by the demat holders for voting for
resolutions of any other company on which they are eligible to vote,
provided that company opts for e-voting through CDSL platform. It is
strongly recommended not to share your password with any other person and
take utmost care to keep your password confidential.
9. For shareholders holding shares in physical form, the details can be used
only for e-voting on the resolutions contained in this Notice.
10. Click on the EVSN for the relevant company <NEXUS SURGICAL AND
MEDICARE LIMITED> on which you choose to vote.
11. On the voting page, you will see “RESOLUTION DESCRIPTION” and
against the same the option “YES/NO” for voting. Select the option YES or
NO as desired. The option YES implies that you assent to the Resolution and
option NO implies that you dissent to the Resolution.
10 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
12. Click on the “RESOLUTIONS FILE LINK” if you wish to view the entire
Resolution details.
13. After selecting the resolution you have decided to vote on, click on
“SUBMIT”. A confirmation box will be displayed. If you wish to confirm
your vote, click on “OK”, else to change your vote, click on “CANCEL” and
accordingly modify your vote.
14. Once you “CONFIRM” your vote on the resolution, you will not be allowed
to modify your vote.
15. You can also take out print of the voting done by you by clicking on “Click
here to print” option on the voting page.
16. If a Demat account holder has forgotten the login password then enter the
User ID and the image verification code and click on Forgot Password &
enter the details as prompted by the system.
• A scanned copy of the Registration Form bearing the stamp and sign of
the entity should be emailed to helpdesk.evoting@cdslindia.com.
11 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
(v) Instructions for shareholders attending the AGM through VC / OAVM and
E-voting During the meeting are as under:
1. The procedure for attending meeting & e-voting on the day of the AGM is
same as the instructions mentioned above for e-voting.
2. The link for VC / OAVM to attend meeting will be available where the
EVSN of Company will be displayed after successful login as per the
instructions mentioned above for e-voting.
4. Shareholders are encouraged to join the Meeting through Laptops / IPads for
better experience.
5. Further shareholders will be required to allow Camera and use Internet with
a good speed to avoid any disturbance during the meeting.
9. Only those shareholders, who are present in the AGM through VC / OAVM
facility and have not casted their vote on the Resolutions through remote e-
Voting and are otherwise not barred from doing so, shall be eligible to vote
through e-Voting system available during the AGM.
10. If any Votes are cast by the shareholders through the e-voting available
during the AGM and if the same shareholders have not participated in the
meeting through VC / OAVM facility, then the votes cast by such
shareholders shall be considered invalid as the facility of e-voting during the
meeting is available only to the shareholders attending the meeting.
11. Shareholders who have voted through Remote e-Voting will be eligible to
attend the AGM. However, they will not be eligible to vote at the AGM.
12 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
(vi) Process for those shareholders whose email addresses are not registered with
the Company / Depositories:
(a) For Physical shareholders - please provide necessary details like Folio No.,
Name of shareholder, scanned copy of the share certificate (front and back),
PAN (self-attested scanned copy of PAN card), AADHAR (self-attested
scanned copy of Aadhar Card) by email to Company / RTA email id.
(b) For Demat shareholders -, Please update your email id & mobile no. with your
respective Depository Participant (DP).
(c) For Individual Demat shareholders - Please update your email id & mobile no.
with your respective Depository Participant (DP) which is mandatory while e-
Voting & joining virtual meetings through Depository.
If you have any queries or issues regarding attending AGM & e-Voting from the CDSL
e-Voting System, you can write an email to helpdesk.evoting@cdslindia.com or contact
at 022- 23058738 and 022-23058542/43.
All grievances connected with the facility for voting by electronic means may be
addressed to Mr. Rakesh Dalvi, Sr. Manager, (CDSL, ) Central Depository Services
(India) Limited, A Wing, 25th Floor, Marathon Futurex, Mafatlal Mill Compounds, N
M Joshi Marg, Lower Parel (East), Mumbai - 400013 or send an email to
helpdesk.evoting@cdslindia.com or call on 022-23058542/43.
13 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Explanatory Statement under Section 102 of the Companies Act, 2013 and the
Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015.
The following Statement sets out all the material facts relating to the Special Business
mentioned in the accompanying Notice:
Item No. 3:
The Board of Directors of the Company, on the recommendation of the Nomination and
Remuneration Committee, at their meeting held on Wednesday, 30th June, 2021, appointed
Ms. Neha Kailash Bhageria (holding DIN 09217784) as an Additional Director - Independent
Woman Director of the Company w.e.f 30th June, 2021.
Pursuant to the provisions of Section 161 of the Act read with the Articles of Association of
the Company, Ms. Neha Kailash Bhageria holds office upto the date of ensuing AGM. The
Company has received notice under Section 160 of the Act from a member proposing the
candidature of Ms. Neha Kailash Bhageria as an Independent Woman Director of the
Company.
Ms. Neha Kailash Bhageria is not disqualified from being appointed as a Director in terms of
Section 164 of the Act and has given her consent to act as an Independent Woman Director.
The Company has received a declaration from Ms. Neha Kailash Bhageria to the effect that
she fulfills all criteria for independence stipulated in the Companies Act, 2013 and the Listing
Regulations. She has also confirmed that she is not debarred from holding the office of
Director by virtue of any SEBI Order or any such authority pursuant to circulars issued by
BSE Limited pertaining to enforcement of SEBI Orders regarding appointment of Directors
by the listed companies.
In the opinion of the Board of Directors, Ms. Neha Kailash Bhageria is independent of the
management of the Company and fulfills the conditions specified in the Companies Act, 2013
and rules made thereunder and Regulation 16 of Listing Regulations for appointment as an
Independent Director. Further the Board of Directors is of the opinion that Ms. Neha Kailash
Bhageria is a person of integrity and has relevant experience and expertise for being
appointed as an Independent Director.
The Board considers that the knowledge, expertise and experience as possessed by Ms. Neha
Kailash Bhageria will be of immense benefit and value to the Company and it is desirable to
avail services of Ms. Neha Kailash Bhageria as an Independent Woman Director for a term of
five consecutive years from September 29, 2021 till September 28, 2026.
The information as required under the Regulation 36 of Listing Regulations and Secretarial
Standard on General Meetings, of Ms. Neha Kailash Bhageria is provided in annexure to this
Notice.
14 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Except Ms. Neha Kailash Bhageria, being the appointee director, none of the other Directors
and the Key Managerial Personnel of the Company and their relatives is concerned or
interested, financial or otherwise, in the resolution set out at Item No. 3 of the Notice.
Item No. 4:
Presently, the registered office of the Company is situated at 111, B/2, Ostwal Ornate, Jesal
Park, Bhayander (East), Thane - 401 105. However, keeping in view the growth potential and
the opportunities in low cost and expenditure in “Palghar District” coupled with the dynamic
and professional human resources, better business opportunities and other physical
infrastructure facilities and connectivity as required for the business, the Company desires to
enlarge, widen, expand and extend the area of operations of the Company. Further, the
shifting of registered office of the Company from “Thane” to “Palghar” and its surrounding
areas will enable to the Company to conduct its operations more conveniently, economically
and efficiently. Furthermore, for ease of administration and better growth in the business it is
proposed to shift the registered office of the Company to Palghar.
The Board of Directors proposes the shifting of the registered office of the Company from its
existing office at Bhayander to Vasai or any other address in Palghar District.
In terms of the applicable provisions of the Companies Act, 2013 and rules made thereunder,
the proposed shifting of registered office requires the Company to obtain necessary approval
of the Members of the Company by way of Special Resolution.
Accordingly, the Board recommends the Special Resolution as set out at Item No. 4 of the
Notice of the AGM for the approval by the members.
None of the Directors and the Key Managerial Personnel of the Company and their relatives
is concerned or interested, financial or otherwise, in the resolution set out at Item No. 4 of the
Notice.
15 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
ANNEXURE
Pursuant to Regulation 36(3) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, Information about the
directors proposed to be appointed / re-appointed is furnished below:
1.
Name of Director Mr. Rupesh Roongta
Date of Birth 12-02-1985
No. of Equity Shares held Nil
Qualification Graduate
Relationship with other Directors None
Nature of Expertise Experience of more than 12 years in the field
of Commodity and Capital Market
Name of Companies in which he holds 1. Sumangal Commodities Private Limited
Directorship 2. Mildred Mercantile Private Limited
Names of Committees of the Companies Stakeholders Relationship Committee
of which he holds membership
2.
Name of Director Ms. Neha Kailash Bhageria
Date of Birth 23-12-1997
No. of Equity Shares held Nil
Qualification Graduate
Relationship with other Directors None
Nature of Expertise Expertise in the field of Marketing and Finance
Name of Companies in which she holds None
Directorship
Names of Committees of the Companies None
of which he / she holds membership
16 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
DIRECTORS' REPORT
To,
The Members,
Nexus Surgical and Medicare Limited
(Formerly known as Nexus Commodities and Technologies Limited)
Your Directors have immense pleasure in presenting their Thirtieth Annual Report on
the business and operations of the Company together with the Audited Statement of
Accounts of the Company for the year ended on 31st March, 2021.
1. Financial Highlights:
(Amount in hundreds)
Particulars For the year ended For the year ended
31st March 2021 31st March 2020
A Total Revenue 3,75,267 173,231
B Total Expenses 3,58,227 1,66,139
C Profit/(Loss) Before Exceptional Item 17,040 7,092
D Exceptional Item:
Capital WIP written off ----- 5,35,049
E Profit/(Loss) Before Tax 17,040 (5,27,957)
F Tax expense
- Current Tax 3,000 1,510
- Tax for earlier years (1,510) -----
- Deferred Tax 150 118
G Profit/(Loss) after Tax 15,400 (5,29,584)
2. Financial Performance:
During the year under review, the Company has earned Total Revenue of Rs. 3,75,267
hundreds in comparison to Rs. 1,73,231 hundreds during the previous year. The
Company has earned net profit of Rs. 15,400 hundreds in comparison to net loss of Rs.
5,29,584 hundreds incurred during the previous year. Your directors are hopeful of
better performance in the forthcoming year. There was no change in the nature of the
business of the Company during the year.
Your Directors abstain from declaring any dividend for the year and no amount of profit
earned during the year was transferred to General Reserve.
Management Discussion & Analysis report is being given under Corporate Governance
Report. There are no material changes between the end of the financial year and the date of
the report which may affect the financial position of the Company.
17 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
At Present, the Equity shares of the Company are listed at BSE Limited.
6. Dematerialization of Shares:
The Company has in place adequate internal financial controls with reference to financial
statements. During the year, such controls were tested and no reportable material
weaknesses in the design or operation were observed.
The Company is having adequate resources at its disposal to meet its business
requirements and for efficient conduct of business. The Company has not raised any funds
by issue of any securities during the year.
The Company does not have any Subsidiary/ Joint Ventures/ Associate Companies.
10. Deposits:
The Company has not accepted any deposits within the meaning of Section 73 of the
Companies Act, 2013, read with the Companies (Acceptance of Deposits) Rules, 2014.
The members of the Company at 28th AGM held on 30th September, 2017 had appointed
M/s. Satya Prakash Natani & Co. (having Firm Registration No. 115438W), Chartered
Accountants, Mumbai, as the Statutory Auditors of the Company for a term of 5 years and
accordingly they hold their office till the conclusion of Annual General Meeting to be held
in the year 2022.
The Auditors’ Report is unmodified i.e. it does not contain any qualification, reservation or
adverse remark or disclaimer.
18 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Pursuant to the provisions of Section 204 of the Companies Act, 2013 and the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, M/s. Nitesh
Chaudhary & Associates, Practicing Company Secretary, Mumbai have been appointed as
Secretarial Auditors of the Company.
The Secretarial Audit Report for the financial year ended March 31, 2021 does not contain
any qualification, which requires any comments from the Board. The Secretarial Audit
Report for financial year ended March 31, 2021 is annexed to this report as Annexure A.
In terms of Section 138 of the Act and Rules made there under, M/s. Vikash Jindal &
Associates, Chartered Accountants, has been appointed as Internal Auditors of the
Company.
Pursuant to Section 92(3) of the Companies Act, 2013 read with Rule 12 of the Companies
(Management and Administration) Rules, 2014, the copy of Annual Return can be
accessed at Company’s website at www.nexusmed.co.in.
Section 134(3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies
(Accounts) Rules, 2014 requires disclosure of the particulars regarding conservation of
Energy and Technology absorption. The Company is not a manufacturing Company;
therefore information required under this clause is not applicable to the Company.
The Company has neither incurred any expenditure nor earned any income in foreign
exchange.
The Company does not fall under the prescribed class of companies’ u/s 135(2) of the
Companies Act, 2013 read with Rule 8 of the Companies (Corporate Social
Responsibility) Rules, 2014. Hence CSR is not applicable to the Company.
Your Company treats its “human resources” as one of its most important assets. Your
Company continuously invests in attraction, retention and development of talent on an
ongoing basis. A number of programs that provide focused people attention are currently
underway. Your Company thrust is on the promotion of talent internally through job
rotation and job enlargement.
19 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
The Board of Directors duly met 6 times during the financial year, the details of the same
are given in the Corporate Governance Report. The intervening gap between the two
consecutive meetings was within the period prescribed under the Companies Act, 2013.
During the year under review, the Company has received Form DIR-8 from all Directors
as required under the provisions of Section 164(2) of the Companies Act, 2013 read with
Companies (Appointment and Qualification of Directors) Rules, 2014 that none of the
Directors of your Company is disqualified to hold office as director and debarred from
holding the office of a Director.
Mr. Rupesh Roongta (holding DIN 02576510), Director of the Company, will retire
by rotation at the ensuing Annual General Meeting and being eligible offers himself
for reappointment.
Pursuant to the provisions of Sections 149, 152 and 161 of the Companies Act, 2013
read with the Companies (Appointment and Qualification of Directors) Rules, 2014
and the Articles of Association of the Company, Ms. Neha Kailash Bhageria
(holding DIN 09217784) was appointed as an Additional Director - Independent
Woman Director on the Board of Directors of the Company w.e.f. 30th June, 2021.
In terms of Section 161 of the Companies Act, 2013, Ms. Neha Kailash Bhageria
holds office upto the conclusion of ensuing Annual General Meeting and being
eligible offers herself for reappointment.
The Company has received declarations from all the Independent Directors of the
Company confirming that they meet the criteria of independence as prescribed under
Section 149(6) of the Companies Act, 2013 and Regulation 16(1)(b) of the Securities
and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
20 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
In order to ensure that the activities of the Company and its employees are conducted in a
fair and transparent manner by adoption of highest standards of professionalism, honesty,
integrity and ethical behavior the company has adopted a vigil mechanism policy.
The Nomination & Remuneration Committee of the Board of Directors has adopted a
policy which deals with the manner of selection and appointment of Directors, Senior
Management and their remuneration. The policy is in compliance with the provisions of
Section 178(3) of the Companies Act, 2013. The Remuneration Policy is stated in the
Report on Corporate Governance.
Details of Loans, Guarantees and Investments covered under the provisions of Section
186 of the Companies Act, 2013 are given in the Notes to the Financial Statements.
All contracts / arrangements / transactions entered into by the Company with its related
parties during the financial year were in the ordinary course of business and on an arm’s
length basis. During the year, the Company has not entered into any material contract /
arrangement / transaction with related parties. Accordingly, disclosure of Related Party
Transactions in Form AOC-2 is not applicable. However, details of transactions with the
related parties have been included in Notes to the Financial Statements.
The Company has adequate internal controls in place at various functional levels and does
not foresee any major risk such as financial, credit, legal, regulatory and other risk keeping
in view the nature and size of its business.
27. Safety:
During the year under review, there were no cases filed pursuant to the Sexual Harassment
of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.
There are no significant and material orders passed by Regulators/Courts that would
impact the going concern status of the Company and its future operations.
No material changes and commitments affecting the financial position of the Company
occurred between the end of the financial year to which this financial statement relates on
the date of this report.
21 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
The Board of Directors has carried out an annual evaluation of its own performance, Board
committees and individual directors pursuant to the provisions of the Act and the corporate
governance requirements as prescribed by Securities and Exchange Board of India under
the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015.
The performance of the Board was evaluated by the Board after seeking inputs from all the
directors on the basis of the criteria such as the Board composition and structure,
effectiveness of board processes, information and functioning, etc.
The performance of the committees was evaluated by the Board after seeking inputs from
the committee members on the basis of the criteria such as the composition of committees,
effectiveness of committee meetings, etc.
The Board of Directors of the Company and the Nomination and Remuneration
Committee reviewed the performance of the individual directors on the basis of the criteria
such as the contribution of the individual director to the Board and committee meetings
like preparedness on the issues to be discussed, meaningful and constructive contribution
and inputs in meetings, etc. In addition, the Chairman was also evaluated on the key
aspects of his role.
The Audit Committee is comprised of three directors. The composition of the Audit
Committee is as follows:-
All the recommendations made by the Audit Committee were accepted by the Board of
Directors.
22 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
All the recommendations made by the Nomination and Remuneration Committee were
accepted by the Board of Directors.
The information required pursuant to Section 197(12) read with Rule 5 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014 and Companies
(Particulars of Employees) Rules, 1975, in respect of employees of the Company and
Directors is furnished hereunder:
Ratio of remuneration of each director to the median remuneration of the employees of the
company and Percentage increase in remuneration of each Director and Key Managerial
Personnel for the financial year ended March 31, 2021:
The particulars of the employees as required under Rule 5(2) and Rule 5(3) of Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014 are not applicable
to the Company as none of the employees of the Company was in receipt of remuneration
as prescribed under the said Rules.
B) Sweat Equity:
The Company has not issued any Sweat Equity Shares during the year under review.
23 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
C) Bonus Shares:
No Bonus Shares were issued during the year under review.
According to the provisions of section 134(3)(c) of the Companies Act, 2013, the directors
confirm that:
a) in the preparation of annual accounts for the financial year ended 31st March, 2021, the
applicable accounting standards read with requirements set out under Schedule III to
the Act, have been followed and there are no material departures from the same;
b) the accounting policies as selected are consistently applied and made judgments and
estimates that are reasonable and prudent manner so as to ensure true and fair view of
the state of affairs of the Company as at 31st March, 2021 and of the profit of the
Company for the year ended on that date;
c) adequate accounting records are maintained in accordance with the provisions of the
Act for safeguarding the assets of the Company and for preventing and detecting fraud
and other irregularities;
e) the Directors have laid down internal financial controls to be followed by the
Company and that such internal financial controls are adequate and are operating
effectively; and
f) the Directors have devised proper systems to ensure compliance with the provisions of
all applicable laws and that such systems are adequate and operating effectively.
37. Acknowledgment:
Your directors take the opportunity to record their deep sense of gratitude for the
valuable support and cooperation extended to the Company by its shareholders and
bankers.
24 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
!
"!#!$#! !#
( >;<>+7==8"/-=387
80=2/869+73/<-=
+7.!>5/880=2/869+73/<
99837=6/7=+7.!/6>7/;+=38780+7+1/;3+5 /;<877/5!>5/<
)
#8
#2//6,/;<
< /A><">;13-+57./.3-+;/363=/.
";<?)4":6)<--;)4#):3
0)A)6,-:);<&0)6- C
'-0)>-+76,=+<-,<0-%-+:-<):1)4=,1<7.<0-+75841)6+-7.)8841+)*4-;<)<=<7:A8:7>1;176;)6,<0-
),0-:-6+-<7+7:87:)<-8:)+<1+-;*A </A><">;13-+57./.3-+;/363=/. 0-:-16).<-: +)44-,<0-
D758)6AE.7: <0- )=,1< 8-:17, +7>-:16/ <0- 16)6+1)4 (-): .:75
;< 8:14 <7
;< ):+0
D<0-)=,1<8-:17,E%-+:-<):1)4=,1<?);+76,=+<-,16)5)66-:<0)<8:7>1,-,=;):-);76)*4-*);1;
.7:->)4=)<16/<0-+7:87:)<-+76,=+<;;<)<=<7:A+75841)6+-;)6,-@8:-;;16/7=:7816176<0-:-76
);-,767=:>-:1.1+)<1767.<0-758)6A;*773;8)8-:;516=<-*773;.7:5;)6,:-<=:61;.14-,)6,
7<0-: :-+7:,; 5)16<)16-, *A <0- 758)6A )6, )4;7 <0- 16.7:5)<176 8:7>1,-, *A <0- 758)6A 1<;
7..1+-:; )/-6<; )6, )=<07:1B-, :-8:-;-6<)<1>-; ,=:16/ <0- +76,=+< 7. %-+:-<):1)4 =,1< ?- 0-:-*A
:-87:<<0)<167=:7816176<0-758)6A0);,=:16/<0-)=,1<8-:17,+7>-:16/<0-.16)6+1)4A-):-6,-,
76
;< ):+0
0); +75841-, ?1<0 <0- ;<)<=<7:A 8:7>1;176; 41;<-, 0-:-=6,-: )6, )4;7 <0)< <0-
758)6A 0); 8:78-: 7):, 8:7+-;;-; )6, +75841)6+-5-+0)61;5 16 84)+- <7 <0- -@<-6< 16 <0-
5)66-:)6,;=*2-+<<7<0-:-87:<16/5),-0-:-16).<-:
'- 0)>- -@)516-, <0- *773; 8)8-:; 516=<-;E *773; .7:5; )6, :-<=:6; .14-, )6, 7<0-: :-+7:,;
5)16<)16-,*A758)6A.7:<0-.16)6+1)4A-):-6,-,76
;< ):+0
)++7:,16/<7<0-8:7>1;176;
7.
1 &0-758)61-;+<
<0-+<)6,<0-:=4-;5),-<0-:-=6,-:
11 &0-%-+=:1<1-;76<:)+<;$-/=4)<176+<
E%$E )6,<0-:=4-;5),-<0-:-=6,-:
111&0--87;1<7:1-;+<
)6,<0-$-/=4)<176;)6,A-4)?;.:)5-,<0-:-=6,-:
> &0-.7447?16/$-/=4)<176;)6,=1,-416-;8:-;+:1*-,=6,-:;-+=:1<1-;)6,@+0)6/-7):,7.
6,1)+<
E%+<
&0- %-+=:1<1-; )6, @+0)6/- 7):, 7. 6,1) %=*;<)6<1)4 +9=1;1<176 7. %0):-; )6, &)3-7>-:;
$-/=4)<176;
&0-%-+=:1<1-;)6,@+0)6/-7):,7.6,1)#:701*1<1767.6;1,-:&:),16/$-/=4)<176;
&0- %-+=:1<1-; )6, @+0)6/- 7):, 7. 6,1) ;;=- 7. )81<)4 )6, 1;+47;=:- $-9=1:-5-6<;
$-/=4)<176; .>;371=2/37+7-3+5'/+;>7./;;/?3/@=2/869+7B2+<78=3<<>/.+7B-+93=+5
+7. 2+< 78= ;+3</. +7B 0>7. =2;8>12 9>,53- /7-/ =2/ ;8?3<387< 80 =2/ <+3. ;/1>5+=387 +;/ 78=
+9953-+,5/=8=2/869+7B
25 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
&0- %-+=:1<1-; )6, @+0)6/- 7):, 7. 6,1) 5847A-- %<7+3 "8<176 %+0-5- )6, 5847A-- %<7+3
#=:+0);-%+0-5-=1,-416-;
)6,&0-%-+=:1<1-;)6,@+0)6/-7):,7.6,1)%0):-);-,
5847A---6-.1<;$-/=4)<176;
.>;371=2/037+7-3+5B/+;>7./;;/?3/@=2/869+7B2+<78=
3<<>/. +7B <2+;/<89=387< =8 .3;/-=8;</6958B//< >7./; =2/ " <+3. 1>3./537/< ;/1>5+=387<
/7-/=2/9;8?3<387<80=2/<+3.;/1>5+=387+;/78=+9953-+,5/=8=2/-869+7B
&0-%-+=:1<1-;)6,@+0)6/-7):,7.6,1);;=-)6,1;<16/7.-*<%-+=:1<1-;$-/=4)<176;
=2/-869+7B2+<78=3<<>/.+7B./,=</->;3=3/<.>;371=2/9/;38.>7./;;/?3/@=2/9;8?3<387<80=2/
<+3.;/1>5+=387+;/78=+9953-+,5/=8=2/-869+7B
&0- %-+=:1<1-; )6, @+0)6/- 7):, 7. 6,1) $-/1;<:):; <7 )6 1;;=- )6, %0):- &:)6;.-: /-6<;
$-/=4)<176;
:-/):,16/ <0- 758)61-; +< )6, ,-)416/ ?1<0 +41-6< 8= +9953-+,5/ =8 =2/
869+7B.>;371=2/>.3=9/;38.
&0-%-+=:1<1-;)6,@+0)6/-7):,7.6,1)-41;<16/7.9=1<A%0):-;$-/=4)<176; =2/
/:>3=B<2+;/<80=2/-869+7B+;/7/3=2/;./53<=/.78;9;898</.=8,/./53<=/./7-/=2/9;8?3<387
80<+3.;/1>5+=38778=+9953-+,5/=8=2/-869+7B
&0- %-+=:1<1-; )6, @+0)6/- 7):, 7. 6,1) =A*)+3 7. %-+=:1<1-; $-/=4)<176;
>;371 =2/
9/;38.>7./;;/?3/@=2/-869+7B2+?/78=,8>12=,+-4+7B</->;3=3/</7-/=2/<+3.;/1>5+=3873<
78=+9953-+,5/=8=2/-869+7B
>1 )>16/ :-/):,; <7 <0- +75841)6+- ;A;<-5 8:->)1416/ 16 <0- 758)6A 16.7:5-)<176 :-8:-;-6<)<176
8:7>1,-, *A 5)6)/-5-6< )6, 76 -@)516)<176 7. <0- :-4->)6< ,7+=5-6<; )6, :-+7:,; 16 8=:;=)6+-
<0-:-7.76<-;<+0-+3*);1;<0-.7447?16/4)?;):-)4;7)8841+)*4-76+758)6A
1 &0-9=)4$-5=6-:)<176+<
11 )0):);0<:);<)<-&)@76#:7.-;;176;&:),-;)4416/;)6,5847A5-6<;+<
111 &0--6<:)477,;6,%-:>1+-;&)@+<
1> )0):);0<:)77,;)6,%-:>1+-;&)@+<
0)>-)4;7-@)516-,+75841)6+-?1<0<0-)8841+)*4-+4)=;-;7.<0-.7447?16/
• %-+:-<):1)4 %<)6,):,; ?1<0 :-;8-+< <7 --<16/ 7. 7):, 7. 1:-+<7:%%
-6-:)4 --<16/ %%)6,
1>1,-6, %% 1;;=-, *A &0- 6;<1<=<- 7. 758)6A %-+:-<):1-; 7. 6,1) :-4)<-, <7 7):, 5--<16/;
-6-:)4 --<16/)6,1>1,-6,
• &0- %-+=:1<1-; )6, @+0)6/- 7):, 7. 6,1) 1;<16/ "*41/)<176; )6, 1;+47;=:- $-9=1:-5-6<;
$-/=4)<176;
=:16/ <0- 8-:17, =6,-: :->1-? <0- 758)6A 0); +75841-, ?1<0 <0- 8:7>1;176; 7. <0- +< $=4-;
$-/=4)<176;=1,-416-; %<)6,):,;-<+5-6<176-,)*7>-
.=:<0-::-87:<<0)<
26 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
11 #:78-: 67<1+- 1; /1>-6 <7 )44 1:-+<7:; <7 ;+0-,=4- <0- 7):, 5--<16/; 16 +75841)6+- ?1<0 <0-
8:7>1;176; 7. %-+<176
7. <0- 758)61-; +<
)/-6,) )6, ,-<)14-, 67<-; 76 )/-6,) ?-:-
;-6< )< 4-);< ;->-6 ,)A; 16 ),>)6+- )6, ?0-:- <0- ;)5- ?-:- /1>-6 )< ;07:<-: 67<1+- <0)6 ;->-6
,)A; 8:78-: +76;-6< <0-:-7. ?-:- 7*<)16-, )6, ) ;A;<-5 -@1;<; .7: ;--316/ )6, 7*<)1616/ .=:<0-:
16.7:5)<176)6,+4):1.1+)<176;76<0-)/-6,)1<-5;*-.7:- <0-5--<16/)6,.7:5-)616/.=48):<1+18)<176
)<<0-5--<16/
111 -+1;176;)<<0-5--<16/;7.<0-7):,7.1:-+<7:;7.<0-758)6A?-:-+)::1-,<0:7=/076<0-*);1;
7. 5)27:1<A &0-:- ?-:- 67 ,1;;-6<16/ >1-?; *A )6A 5-5*-: 7. <0- 7):, 7. 1:-+<7:; ,=:16/ <0-
8-:17,=6,-::->1-?
1> )27:1<A,-+1;1761;+)::1-,<0:7=/0?014-<0-,1;;-6<16/5-5*-:;E>1-?;):-+)8<=:-,)6,
:-+7:,-,);8):<7.<0-516=<-;
> &0-:- ):- ),-9=)<- ;A;<-5; )6, 8:7+-;;-; 16 <0- 758)6A +755-6;=:)<- ?1<0 <0- ;1B- )6,
78-:)<176;7.<0-758)6A<75761<7:)6,-6;=:-+75841)6+-?1<0)8841+)*4-4)?;:=4-;:-/=4)<176;
)6,/=1,-416-;
%/0>;=2/;;/98;==2+= <0-:-):-),-9=)<-;A;<-5;)6,8:7+-;;-;16<0-758)6A+755-6;=:)<-?1<0
<0-;1B-)6,78-:)<176;7.<0-758)6A<75761<7:)6,-6;=:-+75841)6+-?1<0)8841+)*4-4)?;:=4-;
:-/=4)<176;)6,/=1,-416-;
%/0>;=2/;;/98;==2+= ,=:16/<0-)=,1<8-:17,<0-:-?-:-67;8-+1.1+->-6<;)+<176;168=:;=)6+-7.
<0- )*7>- :-.-::-, 4)?; :=4-; :-/=4)<176; /=1,-416-; ;<)6,):,; -<+ 0)>16/ ) 5)27: *-):16/ 76 <0-
758)6AE;)..)1:;-@+-8<<0-.7447?16/
F=:16/ <0- 16)6+1)4 (-): <0- 758)6A 0); )4<-:-, 1<; -57:)6,=5 7. ;;7+1)<176 !)5- 4)=;-
>1,-0)6/-166)5-7.<0-758)6A.:75 /A><8668.3=3/<+7.#/-2785813/<363=/. <7
F/A><">;13-+5+7./.3-+;/363=/.E
8; 3=/<22+>.2+;B<<8-3+=/<
;+-=3-371869+7B"/-;/=+;B
<.
*********************
3=/<22+>.2+;B ;89;3/=8;
"8
8
5+-/>6,+3
+=/=2 >1><=
$
8=/
• #23< ;/98;= 3< =8 ,/ ;/+. @3=2 8>; 5/==/; 80 /?/7 .+=/ @23-2 3< +77/A/. +< D&$! E +7.
08;6<+737=/1;+59+;=30=23<;/98;=
27 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
77/A>;/=8=2/"/-;/=+;3+5>.3=!/98;=
#8
#2//6,/;<
</A><">;13-+57./.3-+;/363=/.
";<?)4":6)<--;)4#):3
0)A)6,-:);<&0)6- C
"=: :-87:<7.->-6,)<-1;<7*-:-),)476/?1<0<01;4-<<-:
+7+1/6/7=C<!/<987<3,353=B
<1;<0-$-;876;1*141<A7. )6)/-5-6<7.<0-758)6A<75)16<)16%-+:-<):1)4:-+7:,;,->1+-
8:78-:;A;<-5;<7-6;=:-+75841)6+-?1<0<0-8:7>1;176;7.)44)8841+)*4- 4)?;)6,:-/=4)<176;
)6,<7-6;=:-<0)<<0-;A;<-5;):-),-9=)<-)6,78-:)<--..-+<1>-4A
>.3=8;C<!/<987<3,353=B
0)>- .7447?-, <0- )=,1< 8:)+<1+-; )6, 8:7+-;;-; ); ?-:- )88:78:1)<- <7 7*<)16 :-);76)*4-
);;=:)6+-)*7=<<0-+7::-+<6-;;7.<0-+76<-6<; 7.<0-%-+:-<):1)4:-+7:,;&0->-:1.1+)<176?);
,76- 76 <0- <-;< *);1; <7 -6;=:- <0)< +7::-+< .)+<; ):- :-.4-+<-, 16 %-+:-<):1)4 :-+7:,; *-41->-
<0)<<0-8:7+-;;-;)6,8:)+<1+-;.7447?-,8:7>1,-):-);76)*4-*);1;.7:7=:7816176
0)>- 67< >-:1.1-, <0- +7::-+<6-;; )6, )88:78:1)<-6-;; 7. .16)6+1)4 :-+7:,; )6, *773; 7.
)++7=6<;7.<0-758)6A
'0-:- ->-: :-9=1:-, 0)>- 7*<)16-, <0- )6)/-5-6< :-8:-;-6<)<176 )*7=< +75841)6+- 7.
4)?;:=4-;)6,:-/=4)<176;)6,0)88-616/;7.->-6<;-<+
&0- +75841)6+- 7. 8:7>1;176; 7. 7:87:)<- )6, 7<0-: )8841+)*4- 4)?; :=4-; :-/=4)<176;
;<)6,):,; 1; <0- :-;876;1*141<A 7. <0- 5)6)/-5-6< "=: -@)516)<176 ?); 4151<-, <7 <0-
>-:1.1+)<1767.8:7+-,=:-;76<-;<*);1;
3<-5+36/;
&0-%-+:-<):1)4=,1<$-87:<1;6-1<0-:)6);;=:)6+-);<7<0-.=<=:->1)*141<A7.<0-758)6A
67: 7. -..1+)+A 7: -..-+<1>-6-;; ?1<0 ?01+0 <0- 5)6)/-5-6< 0); +76,=+<-, <0- )..)1:; 7. <0-
758)6A
8; 3=/<22+>.2+;B<<8-3+=/<
;+-=3-371869+7B"/-;/=+;B
<.
*********************
3=/<2 2+>.2+;B ;89;3/=8;
"8
8
5+-/>6,+3
+=/=2 >1><=
$
28 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
The governance practices followed by your company have played a vital role in its
journey of continued success. All the procedures, policies and practices followed by your
company are based on sound governance principles. Comprehensive disclosures,
structured accountability in exercise of powers and commitment incompliance with
regulations and statues in latter as well as sprit have enabled your company to enhance
shareholder value.
2. BOARD OF DIRECTORS
29 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Independent Director is defined as one who apart from receiving sitting fee as a Director,
does not have any other material pecuniary relationship or transactions in his personal
capacity with the Company, its promoters & management.
(ii) Meetings and Attendance of Directors during the financial year 2020-2021:
During the financial year 2020-21, the Board met 6 times. The meetings were held on
09.06.2020, 30.06.2020, 01.09.2020, 14.09.2020, 10.11.2020 and on 13.02.2021.
30 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
The details of the Policy for the familiarization programmes for the Independent
Directors are hosted on the website of the Company which can be accessed at the
website: www.nexusmed.co.in.
The Board of Directors confirm that the Independent Directors fulfill the conditions
specified in the Act and the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements), 2015 and are independent of management.
3. AUDIT COMMITTEE
The Audit Committee has been mandated with the terms of reference as specified
in Regulation 18 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 & enumerated in
Section 177 of the Companies Act, 2013 and covers all the aspects stipulated by
the Securities and Exchange Board of India Guidelines.
31 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
(iii) Invitee: (being entitled to attend as per relevant provisions of applicable laws /
rules and/or as and when felt necessary)
(iv) An Audit Committee meeting was held on 30th June, 2020 where the Annual
Financial Statements for the year ended 31st March, 2020 were reviewed and
examined by the members of the Audit Committee before recommendation of the
same to the Board of Directors for their perusal and adoption.
The Audit Committee reviewed the Quarterly/ Half Yearly Unaudited Financial
Results on the following dates before recommending the same to the Board.
In accordance with the provisions of Section 178 of Companies Act, 2013 and
requirements of Regulation 19 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, the Company has proper
constitution of Nomination and Remuneration Committee and the terms of reference
before the Committee are as under:
32 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
(a) The Committee shall identify persons who are qualified to become directors and
who may be appointed in senior management in accordance with the criteria laid,
recommend to the Board their appointment and removal and shall carry out
evaluation of every director’s performance.
(b) Formulation of the criteria for determining qualifications, positive attributes and
independence of a director and recommend to the Board a policy, relating to the
remuneration of the Directors, Key Managerial Personnel and other employees.
Remuneration Policy:
The Company’s remuneration policy aims to attract and retain talent and is in
accordance with the industries practices. The policy ensures equity, fairness and
consistency in rewarding the employees on the basis of performance against
earmarked objectives.
The components of the total remuneration vary for different employee grades and are
governed by industry patterns, qualifications and experience of the employee,
responsibilities handled by him.
Pursuant to the Companies Act, 2013 and Regulation 17(10) of the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015, the Board of Directors of the Company has evaluated the
performances of each Independent Director. The Evaluation framework for assessing
the performance of Independent Directors comprises of the following key areas:
33 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
c) Strategic perspectives or inputs regarding future growth of the Company and its
performances;
d) Providing perspectives and feedback going beyond information provided by the
management.
5. REMUNERATION OF DIRECTORS:
In accordance with the provisions of Section 178(5) of the Companies Act, 2013 and
requirements of Regulation 20 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, the terms of reference
before the Stakeholders Relationship Committee of the Board are as under:
(i) The Company has a ‘Stakeholders Relationship Committee’ to review transfer and
transmission of securities, issue of duplicate certificates, review of share
dematerialization and rematerialization, monitoring the performance of company’s
Registrar and Transfer Agent and deals with other Shareholder related issues.
34 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
(iii) Ms. Monika Choudhary has been designated by the Board as the ‘Compliance
Officer’ of the Company for complying with the requirements under Securities
and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015 with the Stock Exchange, Mumbai.
35 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
The Company has carried out postal ballot exercise during the financial year
2020-21, for the following businesses:
The approval of the shareholders was obtained vide Postal Ballot Notice dated 9th
June, 2020. The e-voting commenced on June 16, 2020 and closed on July 15,
2020. Results were declared by the Chairman on July 17, 2020.
8. MEANS OF COMMUNICATION:
36 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
(viii) Performance of the share price of the Company in comparison to the BSE
Sensex:
37 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
38 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
10. DISCLOSURES:
39 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Fees paid to Statutory Auditors : Total fees of Rs. 40,000/- (Rupees Forty
Thousand Only) for the financial year
2020-21, for all the services was paid by
the Company to the Statutory Auditors
and all entities in the network firm/
network entity of which the statutory
auditor is a part.
During the year 2020-21, the Company has complied with the requirements of Corporate
Governance Report as mentioned in sub-paras (2) to (10) of Para C of Schedule V of the
Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements)
Regulations, 2015.
The Company has complied with the Regulations 17 to 27 and Clauses (b) to (i) sub-
regulation (2) of Regulation 46 of Securities and Exchange Board of India (Listing
Obligations & Disclosure Requirements) Regulations, 2015 during the year 2020-21
wherever applicable.
The Company does not have any of its securities lying in demat/unclaimed suspense
account arising out of public/ bonus/ right issues as at 31st March, 2020. Hence, the
particulars relating to aggregate number of shareholders and the outstanding securities in
suspense account and other related matters does not arise.
40 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
I, Ram Swaroop Mahadev Joshi, Whole-time Director of the Company, do hereby declare
that all the Board members and Senior management personnel of the Company have affirmed
their compliance on an annual basis with the Code of Conduct as laid down by the Company
pursuant to requirements of para D of Schedule V of the Securities and Exchange Board of
India (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Sd/-
Ram Swaroop Mahadev Joshi
Place: Thane DIN: 07184085
Dated: 2nd September, 2021 Whole-time Director
41 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
[Pursuant to Regulation 17(8) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015.]
I, Ram Swaroop Mahadev Joshi, Chief Financial Officer and Director of the Company, to
the best of my knowledge and belief, certify that:
(a) I have reviewed the Financial Statements and the Cash Flow Statement for the financial
year ended 31st March, 2021 and that to the best of my knowledge and belief:
(i) these statements do not contain any materially untrue statement or omit any
material fact or contain statements that might be misleading;
(ii) these statements together present a true and fair view of the Company’s affairs
and are in compliance with existing accounting standards, applicable laws and
regulations.
(b) There are, to the best of my knowledge and belief, no transactions entered into by the
Company during the year which are fraudulent, illegal or violative of the Company’s
Code of Conduct.
(c) I accept responsibility for establishing and maintaining internal controls and that I have
evaluated the effectiveness of the internal control systems of the Company and I have
disclosed to the Auditors and the Audit Committee, deficiencies in the design or
operation of internal controls, if any of which we are aware and the steps we have taken
or propose to take to rectify these deficiencies.
(d) I have indicated to the Auditors and the Audit Committee that:
(i) There have not been any significant changes in internal control over financial
reporting during the financial year ended 31st March, 2021;
(ii) There have not been significant changes in the accounting policies during the
financial year ended 31st March, 2021;
(iii) I have not become aware of any significant fraud or involvement therein, if any, of
the management or any employee having a significant role in the Company’s
internal control system over financial reporting.
Sd/-
Place: Thane Ram Swaroop Mahadev Joshi
Dated: 2nd September, 2021 Chief Financial Officer
42 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
%''"!"!&$('"!"%'"%&
8=:;=*6< <7%.0=4*<276
*6-&,1.-=4.)#*:*,4*=;.
27/<1.&2;<260"+420*<276;*6-2;,47;=:.
%.9=2:.5.6<;%.0=4*<276;
'7
'1. .5+.:;
;!.?=;&=:02,*4*6- .-2,*4 252<.-
";<>*4":6*<..;*4#*:3
1*@*6-.:*;<'1*6.
3,?0 0A,6470/ =30 ;050?,7= ;024<=0;< ;0.8;/< 18;6< ;0=>;7< ,7/ /4<.58<>;0< ;0.04?0/ 1;86 =30 4;0.=8;< 81 ;
!.?=; &=:02,*4 *6- .-2,*4 252<.- 7:5*44@ 367>6 *; !.?=; 7557-2<2.; *6- '.,1674702.; 252<.- 3,?472 !
#,7/3,?472 :.02;<.:.- 7//2,. *<
9;8/>.0/ -018;0 60 -B =30 869,7B 18; =30 9>;98<0 81 4<<>472 =34< 0;=414.,=0 47 ,..8;/,7.0 @4=3 %02>5,=487
;0,/@4=3&.30/>50)$,;,&>-.5,><0
481 =30&0.>;4=40<A.3,7208,;/817/4, 4<=472#-542,=487<,7/4<.58<>;0
%0:>4;0607=<%02>5,=487<
7 6B 8947487 ,7/ =8 =30 -0<= 81 6B 4718;6,=487 ,7/ ,..8;/472 =8 =30 ?0;414.,=487< 47.5>/472 4;0.=8;< /07=414.,=487
">6-0;"<=,=><,==30 98;=,5 @@@6.,28?47&,<.87<4/0;0/70.0<<,;B,7/0A95,7,=487<1>;74<30/=860-B
=30869,7B4=<8114.0;<30;0-B.0;=41B=3,=787081=304;0.=8;<87=308,;/81=30869,7B,<<=,=0/-058@18;
=3047,7.4,5+0,;07/47287
<=!,;.3 3,?0-007/0-,;;0/8;/4<:>,54140/1;86-0472,99847=0/8;.87=47>472
,<4;0.=8;<81.869,740<-B=30&0.>;4=40<,7/A.3,7208,;/817/4,!474<=;B818;98;,=011,4;<8;,7B<>.38=30;
&=,=>=8;B>=38;4=B
.=4?0
" &%
.=4?0
1>;=30; 30;0-B 4718;6 =3,= 07<>;472 =30 05424-454=B 18; =30 ,99847=607= .87=47>4=B 81 4;0.=8; 87 =30 8,;/ 4< =30
;0<987<4-454=B 81 =30 869,7B #>; ;0<987<4-454=B 4< =8 4<<>0 =34< .0;=414.,=0 -,<0/ 87 ?0;414.,=487 81 /8.>607=< ,7/
4718;6,=487 ,?,45,-50 47 =30 9>-54. /86,47 '34< .0;=414.,=0 4< 704=30; ,7 ,<<>;,7.0 ,< =8 =30 1>=>;0 ?4,-454=B 81 =30
869,7B78;81=30 0114.407.B8;0110.=4?070<<@4=3@34.3=306,7,20607=3,<.87/>.=0/=30,11,4;<81=30869,7B
7: !2<.;11*=-1*:@;;7,2*<.;
#:*,<2,260758*6@&.,:.<*:@
;-
!2<.;11*=-1*:@
#:78:2.<7:
& !"
#!7
(!
#4*,. =5+*2
*<.
43 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Given the impact of the pandemic, FY2021 was expected to be an extremely demanding year.
The consensus was that GDP growth in FY2021 would not only be negative but also would
constitute the greatest fall in growth since 1979-80.
In fact, the degrowth in GDP was much larger than expected. For April-June 2020, real GDP
contracted by a massive 24.4%. India had never recorded a quarter of negative growth since it
began issuing such data publicly in 1996. No other large economy shrank so much during the
pandemic. In the second quarter, July-September 2020, GDP again contracted by 7.3%. The
consensus was that growth in the second half of the fiscal year would be far less than what
was needed to erase the effect of the deep recession in the first half.
Thankfully, we began to witness early signs on resumption of economic activity in the second
half of the year with several high frequency indicators suggesting that the economy was back
on to positive growth. The third quarter (October-December 2020) recorded a GDP growth of
0.4%. And, as mentioned earlier, the second advance estimates of national income for
FY2021 released by the CSO indicates a negative GDP growth of 8% for FY2021. Though
this was bad enough, the contraction will be far less than earlier thought of — and we should
see the fourth quarter (January-March 2021) showing relatively robust growth.
Commodity markets remained jittery in FY21 due to domestic economic slowdown, concerns
on fiscal slippage and geopolitical tensions. Weaknesses in overall economic activity also put
pressure on business growth.
Your Company is continuously reviewing the evolving situation in the light of COVID-19
and playing a responsible role in minimizing the adverse impact of the pandemic on its
businesses and the stakeholders’ interests..
Company is continuously looking for opportunities of growth in new areas and ventured into
some revenue generating services that can boost financial health of the company. As regards
threat due to COVID-19 demand of commodities affected badly, also forex volatility could be
a major threat.
Segment-wise/Product-wise Performance:
Your Company has only one reporting segment. The revenue for the year was Rs. 374.42
lakhs.
Outlook:
The markets presently are subdued due to COVID-19 and how sooner it will revive is not
easy to predict. However, with the industry’s increasing preparedness, the evolving
opportunities can be better harvested.
44 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Economic downturn in recent month, which could pose a risk, should it not be tamed quickly.
The entry permit regime for trade within country should end immediately. The Government
should continue its initiative of Ease of Doing Business. During the year your Company
under its well planned and defined risk management policy gave attention to all the risk areas.
The Board of Directors is apprised of the development in risk management in periodical
meetings where the quarterly results are approved.
Your Company has a planned internal control system through internal checks and reviews it
periodically to strengthen it and safeguard Company’s assets. Management Information
System is given upmost importance.
During the year under review, the Company has earned Total Revenue of Rs. 375.27 lakhs in
comparison to Rs. 173.23 lakhs during the previous year. The Company has reported a net
profit of Rs. 15.40 in comparison to net loss of Rs. 529.58 lakhs (including Rs. 535.05 lakhs
for Exceptional Item) during the previous year.
Your Company as a matter of policy gives greater importance to safety, health and
environment and also ensures compliance with applicable legislative requirements.
Human Resources:
Your Company recognizes the importance of Human Resource in achieving its objectives and
strategies as human resource plays an important role in the success and growth of Company.
Your company gives priority in honing and utilizing their skills through in house training
programs.
In accordance with the SEBI (Listing Obligations and disclosures Requirements) Regulations
2018 (Amendment) Regulations, 2018, the Company is required to give details of significant
changes (change of 25% or more as compared to the immediately previous financial year) in
Key sector-specific financial ratios.
45 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
Cautionary Statement:
The report contains forward looking statements describing expectations, estimates, plans or
words with similar meaning. Your Company’s actual result may differ from those projected
depending on various factor. Your Company cannot guarantee that the assumptions and
estimates in the forward looking statements are accurate or will be realized.
46 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
6-.8.6-.6<=-2<7:;B %.87:<
);@41#19.1>?;2 ".@=;&=:02,*4*6-!.-2,*:. 252<.-
7:5.:4A67?6 *; ".@=;7557-2<2.;*6-'.,1674702.; 252<.-
%.87:<76<1.=-2<7/<1.&<*6-*476.26*6,2*4&<*<.5.6<;
#826276
,1 4-B1 -A05@10 @41 -//;9<-:E5:3 ?@-:0-8;:1 25:-:/5-8 ?@-@191:@? ;2 $1DA? (A>35/-8 -:0
#105/->1"595@10 H@41;9<-:EIC45/4/;9<>5?1@41-8-:/1(411@-?-@#->/4
@41
(@-@191:@;2&>;25@-:0";??5:/8A05:3%@41>;9<>141:?5B1 :/;91 @41(@-@191:@;24-:31?
5:=A5@E-:0@41(@-@191:@;2-?48;C?2;>@41E1->1:010;:@4-@0-@1-:0-?A99->E;2@41
?53:525/-:@-//;A:@5:3<;85/51?-:0;@41>1D<8-:-@;>E5:2;>9-@5;:41>15:-2@1>>121>>10@;-?H@41
?@-:0-8;:125:-:/5-8?@-@191:@?I
:;A>;<5:5;:-:0@;@41.1?@;2;A>5:2;>9-@5;:-:0-//;>05:3@;@411D<8-:-@5;:?35B1:@;A?
@41 -2;>1?-50 ?@-:0-8;:1 25:-:/5-8 ?@-@191:@? 35B1 @41 5:2;>9-@5;: >1=A5>10 .E @41 ;9<-:51?
/@
H@41/@I5:@419-::1>?;>1=A5>10-:035B1-@>A1-:0 2-5>B51C5:/;:2;>95@EC5@4
@41 :05-://;A:@5:3(@-:0->0?<>1?/>5.10A:01>?1/@5;:
;2@41/@>1-0C5@4@41;9<-:51?
:05-: //;A:@5:3 (@-:0->0? 'A81?
-? -91:010 H :0 (I -:0 ;@41> -//;A:@5:3
<>5:/5<81?31:1>-88E-//1<@105: :05-;2 @41?@-@1;2-22-5>?;2@41;9<-:E-?-@#->/4
@41 <>;25@ 5:/8A05:3 ;@41> /;9<>141:?5B1 5:/;91 /4-:31? 5: 1=A5@E -:0 5@? /-?4 28;C? 2;> @41
E1->1:010;:@4-@0-@1
*;2;/7:#826276
,1 /;:0A/@10 ;A> -A05@ 5: -//;>0-:/1 C5@4 @41 (@-:0->0? ;: A05@5:3 (? ?<1/52510 A:01>
?1/@5;:
;2 @41 ;9<-:51? /@
%A> >1?<;:?5.585@51? A:01> @4;?1 (@-:0->0? ->1
2A>@41>01?/>5.105:@41
?1/@5;:
;2;A>>1<;>@,1->15:01<1:01:@;2@41;9<-:E5:-//;>0-:/1C5@4@41;01;2@45/?5??A10
.E@41 :?@5@A@1;24->@1>10//;A:@-:@?;2 :05-@;31@41>C5@4@411@45/-8>1=A5>191:@?@4-@->1
>181B-:@@;;A>-A05@;2@4125:-:/5-8?@-@191:@?A:01>@41<>;B5?5;:?;2@41;9<-:51?/@
-:0 @41 'A81? @41>1A:01> -:0 C1 4-B1 2A8258810 ;A> ;@41> 1@45/-8 >1?<;:?5.585@51? 5: -//;>0-:/1
C5@4 @41?1 >1=A5>191:@? -:0 @41 ;01 ;2 @45/? ,1 .1851B1 @4-@ @41 -A05@ 1B501:/1 C1 4-B1
;.@-5:105??A225/51:@-:0-<<>;<>5-@1@;<>;B501-.-?5?2;>;A>;<5:5;:
.A=-2<!*<<.:;
!1E-A05@9-@@1>?->1@4;?19-@@1>?@4-@5:;A><>;21??5;:-86A0391:@C1>1;29;?@?53:525/-:/1
5: ;A> -A05@ ;2 @41 ?@-:0-8;:1 25:-:/5-8 ?@-@191:@? ;2 @41 /A>>1:@ <1>5;0 )41?1 9-@@1>? C1>1
-00>1??10 5:@41 /;:@1D@ ;2;A> -A05@ ;2@41 ?@-:0-8;:125:-:/5-8 ?@-@191:@? -? - C4;81 -:0 5:
2;>95:3 ;A> ;<5:5;: @41>1;: -:0 C1 0; :;@ <>;B501 - ?1<->-@1 ;<5:5;: ;: @41?1 9-@@1>? ,1
4-B101@1>95:10@4-@@41>1->1:;71E-A05@9-@@1>?@;/;99A:5/-@15:;A>>1<;>@
6/7:5*<276#<1.:<1*6<1.&<*6-*476.26*6,2*4&<*<.5.6<;*6-=-2<7:B;%.87:<'1.:.76
)41;9<-:EG?;->0;25>1/@;>? ->1 >1?<;:?5.812;>@41<>1<->-@5;:;2@41;@41>5:2;>9-@5;:
)41 ;@41> 5:2;>9-@5;: /;9<>5?1? @41 5:2;>9-@5;: 5:/8A010 5: @41 /;9<-:EG? -::A-8 >1<;>@ .A@
0;1?:;@5:/8A01@41?@-:0-8;:125:-:/5-8?@-@191:@?-:0;A>-A05@;>G?>1<;>@@41>1;:
47 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
%A>;<5:5;:;:@41?@-:0-8;:125:-:/5-8?@-@191:@?0;1?:;@/;B1>@41;@41>5:2;>9-@5;:-:0C1
0;:;@1D<>1??-:E2;>9;2-??A>-:/1/;:/8A?5;:@41>1;:
:/;::1/@5;:C5@4;A>-A05@;2@41?@-:0-8;:125:-:/5-8?@-@191:@?;A>>1?<;:?5.585@E5?@;>1-0
@41 ;@41> 5:2;>9-@5;: -:0 5: 0;5:3 ?; /;:?501> C41@41> @41 ;@41> 5:2;>9-@5;: 5? 9-@1>5-88E
5:/;:?5?@1:@ C5@4 @41 ?@-:0-8;:1 25:-:/5-8 ?@-@191:@? ;> ;A> 7:;C81031 ;.@-5:10 0A>5:3 @41
/;A>?1;2;A>-A05@;>;@41>C5?1-<<1->?@;.19-@1>5-88E95??@-@10
2.-?10;:@41C;>7C1 4-B1<1>2;>910C1/;:/8A01@4-@@41>15?-9-@1>5-895??@-@191:@;2
@45? ;@41> 5:2;>9-@5;: C1 ->1 >1=A5>10 @; >1<;>@ @4-@ 2-/@ ,1 4-B1 :;@45:3 @; >1<;>@ 5: @45?
>13->0
!*6*0.5.6<B;%.;876;2+242<A/7:<1.&<*6-*476.26*6,2*4&<*<.5.6<;
)41;9<-:EG?;->0;25>1/@;>?5?>1?<;:?5.812;>@419-@@1>??@-@105:?1/@5;:
;2@41/@
C5@4>1?<1/@@;@41<>1<->-@5;:;2@41?1?@-:0-8;:125:-:/5-8?@-@191:@?@4-@35B1-@>A1-:02-5>
B51C ;2 @41 25:-:/5-8 <;?5@5;: 25:-:/5-8 <1>2;>9-:/1 @;@-8 /;9<>141:?5B1 5:/;91 /4-:31? 5:
1=A5@E -:0 /-?4 28;C? ;2 @41 ;9<-:E 5: -//;>0-:/1 C5@4 @41 :0 ( -:0 ;@41> -//;A:@5:3
<>5:/5<81? 31:1>-88E -//1<@10 5: :05- )45? >1?<;:?5.585@E -8?; 5:/8A01? 9-5:@1:-:/1;2 -01=A-@1
-//;A:@5:3>1/;>0?5:-//;>0-:/1C5@4@41<>;B5?5;:?;2@41/@2;>?-213A->05:3@41-??1@?;2@41
;9<-:E -:0 2;> <>1B1:@5:3 -:0 01@1/@5:3 2>-A0? -:0 ;@41> 5>>13A8->5@51? ?181/@5;: -:0
-<<85/-@5;: ;2 -<<>;<>5-@1 -//;A:@5:3 <;85/51? 9-75:3 6A0391:@? -:0 1?@59-@1? @4-@ ->1
>1-?;:-.81 -:0 <>A01:@ -:0 01?53: 59<8191:@-@5;: -:0 9-5:@1:-:/1 ;2 -01=A-@1 5:@1>:-8
25:-:/5-8/;:@>;8?@4-@C1>1;<1>-@5:31221/@5B18E2;>1:?A>5:3@41-//A>-/E-:0/;9<81@1:1??;2
@41-//;A:@5:3>1/;>0?>181B-:@@;@41<>1<->-@5;:-:0<>1?1:@-@5;:;2@41?@-:0-8;:125:-:/5-8
?@-@191:@?@4-@35B1-@>A1-:02-5>B51C-:0->12>112>;99-@1>5-895??@-@191:@C41@41>0A1
@;2>-A0;>1>>;>
: <>1<->5:3 @41 ?@-:0-8;:1 25:-:/5-8 ?@-@191:@? 9-:-3191:@ 5? >1?<;:?5.81 2;> -??1??5:3 @41
;9<-:EG? -.585@E @; /;:@5:A1 -? - 3;5:3 /;:/1>: 05?/8;?5:3 -? -<<85/-.81 9-@@1>? >18-@10 @;
3;5:3/;:/1>:-:0A?5:3@413;5:3/;:/1>:.-?5?;2-//;A:@5:3A:81??9-:-3191:@15@41>5:@1:0?
@;85=A50-@1@41;9<-:E;>@;/1-?1;<1>-@5;:?;>4-?:;>1-85?@5/-8@1>:-@5B1.A@@;0;?;
)41;->0;2 5>1/@;>?->1>1?<;:?5.812;>;B1>?115:3@41;9<-:EG?25:-:/5-8>1<;>@5:3<>;/1??
=-2<7:B;%.;876;2+242<2.;/7:<1.=-2<7/<1.&<*6-*476.26*6,2*4&<*<.5.6<;
%A> ;.61/@5B1? ->1 @; ;.@-5: >1-?;:-.81 -??A>-:/1 -.;A@ C41@41> @41 ?@-:0-8;:1 25:-:/5-8
?@-@191:@?-?-C4;81->12>112>;99-@1>5-895??@-@191:@C41@41>0A1@;2>-A0;>1>>;>-:0@;
5??A1 -: -A05@;>G? >1<;>@ @4-@ 5:/8A01? ;A> ;<5:5;: '1-?;:-.81 -??A>-:/1 5? - 4534 81B18 ;2
-??A>-:/1 .A@ 5? :;@ - 3A->-:@11 @4-@ -: -A05@ /;:0A/@10 5: -//;>0-:/1 C5@4 (? C588 -8C-E?
01@1/@-9-@1>5-895??@-@191:@C41:5@1D5?@?#5??@-@191:@?/-:->5?12>;92>-A0;>1>>;>-:0
->1/;:?501>109-@1>5-8525:05B50A-88E;>5:@41-33>13-@1@41E/;A80>1-?;:-.8E.11D<1/@10@;
5:28A1:/1 @41 1/;:;95/ 01/5?5;:? ;2 A?1>? @-71: ;: @41 .-?5? ;2 @41?1 ?@-:0-8;:1 25:-:/5-8
?@-@191:@?
? <->@ ;2 -: -A05@ 5: -//;>0-:/1 C5@4 (? C1 1D1>/5?1 <>;21??5;:-8 6A0391:@ -:0 9-5:@-5:
<>;21??5;:-8?71<@5/5?9@4>;A34;A@@41-A05@,1-8?;
J 01:@52E -:0 -??1?? @41 >5?7? ;2 9-@1>5-8 95??@-@191:@ ;2 @41 ?@-:0-8;:1 25:-:/5-8
?@-@191:@? C41@41> 0A1 @; 2>-A0 ;> 1>>;> 01?53: -:0 <1>2;>9 -A05@ <>;/10A>1?
48 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
>1?<;:?5B1@; @4;?1 >5?7? -:0 ;.@-5: -A05@ 1B501:/1 @4-@ 5? ?A225/51:@ -:0 -<<>;<>5-@1 @;
<>;B501-.-?5?2;>;A>;<5:5;:)41>5?7;2:;@01@1/@5:3-9-@1>5-895??@-@191:@>1?A8@5:3
2>;9 2>-A0 5? 45341> @4-: 2;> ;:1 >1?A8@5:3 2>;9 1>>;> -? 2>-A0 9-E 5:B;8B1 /;88A?5;:
2;>31>E5:@1:@5;:-8;95??5;:?95?>1<>1?1:@-@5;:?;>@41;B1>>501;25:@1>:-8/;:@>;8
J%.@-5:-:A:01>?@-:05:3;25:@1>:-8/;:@>;8>181B-:@@;@41-A05@5:;>01>@;01?53:-A05@
<>;/10A>1?@4-@->1-<<>;<>5-@15:@41/5>/A9?@-:/1?*:01>(1/@5;:
5;2@41/@
C1->1-8?;>1?<;:?5.812;>1D<>1??5:3;A>;<5:5;:;:C41@41>@41/;9<-:E4-?-01=A-@1
5:@1>:-825:-:/5-8 /;:@>;8? C5@4 >121>1:/1@; ?@-:0-8;:1 25:-:/5-8 ?@-@191:@? 5: <8-/1 -:0
@41;<1>-@5:31221/@5B1:1??;2?A/4/;:@>;8?
J B-8A-@1 @41 -<<>;<>5-@1:1?? ;2 -//;A:@5:3 <;85/51? A?10 -:0 @41 >1-?;:-.81:1?? ;2
-//;A:@5:31?@59-@1?-:0>18-@1005?/8;?A>1?9-01.E 9-:-3191:@
J ;:/8A01 ;: @41 -<<>;<>5-@1:1?? ;2 9-:-3191:@G? A?1 ;2 @41 3;5:3 /;:/1>: .-?5? ;2
-//;A:@5:3 -:0 .-?10 ;: @41 -A05@ 1B501:/1 ;.@-5:10 C41@41> - 9-@1>5-8 A:/1>@-5:@E
1D5?@? >18-@10 @; 1B1:@? ;> /;:05@5;:? @4-@ 9-E /-?@ ?53:525/-:@ 0;A.@ ;: @41 ;9<-:EG?
-.585@E@;/;:@5:A1-?-3;5:3/;:/1>: 2C1/;:/8A01@4-@-9-@1>5-8A:/1>@-5:@E1D5?@?C1
->1 >1=A5>10 @; 0>-C -@@1:@5;: 5: ;A> -A05@;>G? >1<;>@ @; @41 >18-@10 05?/8;?A>1? 5: @41
?@-:0-8;:1 25:-:/5-8 ?@-@191:@? ;> 52 ?A/4 05?/8;?A>1? ->1 5:-01=A-@1 @; 9;052E ;A>
;<5:5;:%A>/;:/8A?5;:?->1.-?10;:@41-A05@1B501:/1;.@-5:10A<@;@410-@1;2;A>
-A05@;>?>1<;>@;C1B1>2A@A>11B1:@?;>/;:05@5;:?9-E/-A?1@41;9<-:E@;/1-?1@;
/;:@5:A1-?-3;5:3/;:/1>:
J B-8A-@1 @41 ;B1>-88 <>1?1:@-@5;: ?@>A/@A>1 -:0 /;:@1:@ ;2 @41 ?@-:0-8;:1 25:-:/5-8
?@-@191:@? 5:/8A05:3 @41 05?/8;?A>1? -:0 C41@41> @41 ?@-:0-8;:1 25:-:/5-8 ?@-@191:@?
>1<>1?1:@ @41 A:01>8E5:3 @>-:?-/@5;:? -:0 1B1:@? 5: - 9-::1> @4-@ -/451B1? 2-5>
<>1?1:@-@5;:
,1 /;99A:5/-@1 C5@4 @4;?1 /4->310 C5@4 3;B1>:-:/1 >13->05:3 -9;:3 ;@41> 9-@@1>? @41
<8-::10 ?/;<1 -:0 @595:3 ;2 @41 -A05@ -:0 ?53:525/-:@ -A05@ 25:05:3? 5:/8A05:3 -:E ?53:525/-:@
0125/51:/51?5:5:@1>:-8/;:@>;8@4-@C1501:@52E0A>5:3;A>-A05@
,1 -8?; <>;B501 @4;?1 /4->310 C5@4 3;B1>:-:/1 C5@4 - ?@-@191:@ @4-@ C1 4-B1 /;9<8510 C5@4
>181B-:@ 1@45/-8 >1=A5>191:@? >13->05:3 5:01<1:01:/1 -:0 @; /;99A:5/-@1 C5@4 @419 -88
>18-@5;:?45<? -:0 ;@41> 9-@@1>? @4-@ 9-E >1-?;:-.8E .1 @4;A34@ @; .1-> ;: ;A> 5:01<1:01:/1
-:0 C41>1-<<85/-.81>18-@10?-213A->0?
>;9 @41 9-@@1>? /;99A:5/-@10 C5@4 @4;?1 /4->310 C5@4 3;B1>:-:/1 C1 01@1>95:1 @4;?1
9-@@1>?@4-@C1>1;29;?@?53:525/-:/15:@41-A05@;2@41?@-:0-8;:125:-:/5-8?@-@191:@?;2@41
/A>>1:@ <1>5;0 -:0 ->1 @41>12;>1 @41 71E -A05@ 9-@@1>? ,1 01?/>5.1 @41?1 9-@@1>? 5: ;A>
-A05@;>?G>1<;>@A:81??8-C;>>13A8-@5;:<>1/8A01?<A.85/05?/8;?A>1-.;A@@419-@@1>;>C41:5:
1D@>1918E >->1 /5>/A9?@-:/1? C1 01@1>95:1 @4-@ - 9-@@1> ?4;A80 :;@ .1 /;99A:5/-@10 5: ;A>
>1<;>@.1/-A?1@41-0B1>?1/;:?1=A1:/1?;20;5:3?;C;A80>1-?;:-.8E.11D<1/@10@;;A@C1534
@41<A.85/5:@1>1?@.1:125@?;2?A/4/;99A:5/-@5;:
%.87:<76#<1.: .0*4*6-%.0=4*<7:A%.9=2:.5.6<;
?>1=A5>10.E@41;9<-:51?A05@;>?G'1<;>@%>01>
H@41%>01>I5??A10.E@41
1:@>-8;B1>:91:@;2 :05-5:@1>9?;2(1/@5;:
;2@41/@C135B15: C66.@=:.
49 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
?>1=A5>10.E(1/@5;:
;2@41/@C1>1<;>@@4-@
- ,14-B1?;A34@-:0;.@-5:10-88@415:2;>9-@5;:-:01D<8-:-@5;:?C45/4@;@41.1?@;2
;A>!:;C81031-:0.18512C1>1:1/1??->E2;>@41<A><;?1?;2;A>-A05@
. : ;A> ;<5:5;: <>;<1> .;;7? ;2 -//;A:@ -? >1=A5>10 .E 8-C 4-B1 .11: 71<@ .E @41
;9<-:E?;2->-?5@-<<1->?2>;9;A>1D-95:-@5;:;2@4;?1.;;7?
/ )41 (@-:0-8;:1 -8-:/1 (411@ @41 (@-@191:@ ;2 &>;25@ -:0 ";?? 5:/8A05:3 ;@41>
/;9<>141:?5B1 5:/;91 (@-@191:@ ;2 4-:31? 5: =A5@E -:0 @41 (@-@191:@ ;2 -?4
8;C01-8@C5@4.E@45?'1<;>@->15:-3>1191:@C5@4@41.;;7?;2-//;A:@
0 : ;A> ;<5:5;: @41 -2;>1?-50 ?@-:0-8;:1 25:-:/5-8 ?@-@191:@? /;9<8E C5@4 @41
//;A:@5:3(@-:0->0??<1/52510A:01>(1/@5;:
;2@41/@
1 %: @41 .-?5? ;2 @41 C>5@@1: >1<>1?1:@-@5;:? >1/15B10 2>;9 @41 05>1/@;>? -? ;: #->/4
-:0 @-71: ;: >1/;>0 .E @41 ;->0 ;2 5>1/@;>? :;:1 ;2 @41 05>1/@;>? 5?
05?=A-852510 -? ;: #->/4
2>;9 .15:3 -<<;5:@10 -? - 05>1/@;> 5: @1>9? ;2
(1/@5;:;2@41/@
2 ,5@4>1?<1/@@;@41-01=A-/E;2@415:@1>:-825:-:/5-8/;:@>;8;B1>25:-:/5-8>1<;>@5:3
;2@41;9<-:E-:0@41;<1>-@5:31221/@5B1:1??;2?A/4/;:@>;8?>121>@;;A>?1<->-@1
>1<;>@5:H66.@=:.I
3 : ;A> ;<5:5;: @41 9-:-31>5-8 >19A:1>-@5;:2;> @41 E1-> 1:010#->/4
4-?
.11:<-50 <>;B5010.E@41 ;9<-:E@;5@?05>1/@;>?5:-//;>0-:/1C5@4@41<>;B5?5;:?
;2?1/@5;:>1-0C5@4(/410A81+@;@41/@
4 ,5@4>1?<1/@@;@41;@41>9-@@1>?@;.15:/8A0105:@41A05@;>G?'1<;>@5:-//;>0-:/1
C5@4'A81;2@41;9<-:51?A05@-:0A05@;>?'A81?
5:;A>;<5:5;:-:0@;
@41.1?@;2;A>5:2;>9-@5;:-:0-//;>05:3@;@411D<8-:-@5;:?35B1:@;A?
5 )41 ;9<-:E 0;1? :;@ 4-B1 -:E <1:05:3 85@53-@5;:? C45/4 C;A80 59<-/@ 5@?
25:-:/5-8<;?5@5;:
55 )41 ;9<-:E 050 :;@ 4-B1 -:E 8;:3@1>9 /;:@>-/@? 5:/8A05:3 01>5B-@5B1
/;:@>-/@?2;>C45/4@41>1C1>1-:E9-@1>5-82;>1?11-.818;??1?
555 )41>1C1>1:;-9;A:@?C45/4C1>1>1=A5>10@;.1@>-:?21>>10@;@41 :B1?@;>
0A/-@5;:-:0&>;@1/@5;:A:0.E@41;9<-:E
7:*6-76+.1*4/7/
&*<A*$:*3*;1"*<*627
1*:<.:.-,,7=6<*6<;
2:5;%.02;<:*<276"7
)
&-
&*<A*$:*3*;1"*<*62
!=5+*2 $*:<6.:
=6.
!.5+.:;128"7
("
50 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
66.@=:.<7<1.6-.8.6-.6< =-2<7:;B%.87:<
'121>>10@;5:&->-3>-<4A:01>F'1<;>@;:%@41>"13-8-:0'13A8-@;>E'1=A5>191:@?G?1/@5;:;2
;A>'1<;>@@;@41919.1>?;2 ".@=;&=:02,*4*6-!.-2,*:. 252<.- ;21B1:0-@1
5 - )41 ;9<-:E 4-? 9-5:@-5:10 <>;<1> >1/;>0? ?4;C5:3 2A88 <->@5/A8->?
5:/8A05:3=A-:@5@-@5B101@-58?-:0?5@A-@5;:;225D10-??1@?
. ? 1D<8-5:10 @; A? -88 @41 25D10 -??1@? 4-B1 .11: <4E?5/-88E B1>52510 .E @41
9-:-3191:@0A>5:3@41<1>5;0-:0:;9-@1>5-805?/>1<-:/51?C1>1:;@5/10
;:?A/4<4E?5/-8 B1>525/-@5;:
/ )41;9<-:E050:;@;C:-:E599;B-.81<>;<1>@E0A>5:3@41E1->
55 ?1D<8-5:10@;A??@;/74-B1.11:<4E?5/-88EB1>52510.E@419-:-3191:@-@
>1-?;:-.81 5:@1>B-8? -:0 :; 9-@1>5-8 05?/>1<-:/51? C1>1 :;@5/10 ;: ?A/4
<4E?5/-8B1>525/-@5;:
555 //;>05:3@;@415:2;>9-@5;:-:01D<8-:-@5;:?35B1:@;A?-:0;:@41.-?5?;2
;A>1D-95:-@5;:;2@41.;;7?;2-//;A:@@41;9<-:E4-?:;@3>-:@10-:E
8;-:??1/A>10;>A:?1/A>10@;/;9<-:51?25>9?;>;@41><->@51? /;B1>105:
@41>135?@1>9-5:@-5:10A:01>(1/@5;:;2@41;9<-:51?/@
0A>5:3
@41E1->;:?1=A1:@8E@41<>;B5?5;:?;2/8-A?1?555- @; 555/;2@41;>01>
->1:;@-<<85/-.81@;@41;9<-:E
B )41;9<-:E4-?:;@-//1<@10-:E01<;?5@?2>;9@41<A.85/-:041:/1@41
05>1/@5B1?5??A10.E@41'1?1>B1-:7;2 :05--:0@41<>;B5?5;:?;2(1/@5;:?
@; ;> -:E ;@41> >181B-:@ <>;B5?5;:? ;2 @41 /@ -:0 @41 ;9<-:51?
//1<@-:/1 ;2 1<;?5@ 'A81?
C5@4 >13->0 @; @41 01<;?5@? -//1<@10
2>;9@41<A.85/->1:;@-<<85/-.81
B5 ?<1>5:2;>9-@5;:1D<8-:-@5;:35B1:.E@419-:-3191:@9-5:@1:-:/1;2
/;?@>1/;>0?4-?:;@.11:<>1?/>5.10.E@411:@>-8;B1>:91:@A:01>?A.
?1/@5;:;2?1/@5;:;2@41;9<-:51?/@
B55 - //;>05:3 @; @41 >1/;>0? ;2 @41 /;9<-:E A:05?<A@10 ?@-@A@;>E 0A1?
5:/8A05:3 &>;B501:@ A:0 :B1?@;> 0A/-@5;: -:0 &>;@1/@5;: A:0
9<8;E11?G (@-@1 :?A>-:/1 :/;91@-D (-81?@-D ,1-8@4 )-D (1>B5/1 )-D
A?@;9A@ED/5?1A@E;;0?(1>B5/1)-D 1??@;@411D@1:@-<<85/-.81
-:0 -:E ;@41> ?@-@A@;>E 0A1? 4-B1 31:1>-88E .11: >13A8->8E 01<;?5@10 C5@4
51 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
. //;>05:3 @; @41 5:2;>9-@5;: -:0 1D<8-:-@5;:? 35B1: @; A? @41>1 5? :;
-9;A:@?<-E-.815:>1?<1/@;25:/;91@-DC1-8@4@-D?1>B5/1@-D?-81?@-D
/A?@;9? 0A@E ;;0? (1>B5/1 )-D -:0 1D/5?1 0A@E C45/4 4-B1 :;@ .11:
01<;?5@10;:-//;A:@;2-:E05?<A@1?
B555 :;A>;<5:5;:-:0-//;>05:3@;@415:2;>9-@5;:-:01D<8-:-@5;:?35B1:@;A?
@41 ;9<-:E 4-? :;@ 012-A8@10 5: @41 >1<-E91:@ ;2 0A1? @; .-:7? )41
;9<-:E4-?:;@@-71:-:E8;-:15@41>2>;925:-:/5-85:?@5@A@5;:?;>2>;9@41
3;B1>:91:@-:04-?:;@5??A10-:E01.1:@A>1?
5D -?10 A<;: @41 -A05@ <>;/10A>1? <1>2;>910 -:0 @41 5:2;>9-@5;: -:0
1D<8-:-@5;:? 35B1: .E @41 9-:-3191:@ @41 /;9<-:E 4-? :;@ >-5?10 -:E
9;:1E.EC-E;2)1>9";-:0A>5:3@41E1->
D -?10 A<;: @41 -A05@ <>;/10A>1? <1>2;>910 -:0 @41 5:2;>9-@5;: -:0
1D<8-:-@5;:? 35B1: .E @41 9-:-3191:@ C1 >1<;>@ @4-@ :; 2>-A0 .E @41
;9<-:E;>;:@41/;9<-:E.E5@?;225/1>?;>19<8;E11?4-?.11::;@5/10;>
>1<;>@100A>5:3@41E1->
D5 : ;A> ;<5:5;: -:0 -//;>05:3 @; @41 5:2;>9-@5;: -:0 1D<8-:-@5;:? @41
;9<-:E 4-? <-50 <>;B5010 9-:-31>5-8 >19A:1>-@5;: 5: -//;>0-:/1 C5@4
@41 >1=A5?5@1 -<<>;B-8 9-:0-@10 .E @41 <>;B5?5;: ;2 ?1/@5;: >1-0 C5@4
(/410A81+@;@41;9<-:51?/@
D55 : ;A> ;<5:5;: @41 ;9<-:E 5? :;@ - $5045 ;9<-:E )41>12;>1 @41
<>;B5?5;:?;2/8-A?1
D55;2@41%>01>->1:;@-<<85/-.81@;@41;9<-:E
D555 :;A>;<5:5;:-88@>-:?-/@5;:?C5@4@41>18-@10<->@51?->15:/;9<85-:/1C5@4
?1/@5;: -:0 ;2 ;9<-:51? /@
-:0 @41 01@-58? 4-B1 .11:
05?/8;?105:@415:-:/5-8(@-@191:@?-?>1=A5>10.E@41-<<85/-.81-//;A:@5:3
?@-:0->0?
D5B -?10 A<;: @41 -A05@ <>;/10A>1? <1>2;>910 -:0 @41 5:2;>9-@5;: -:0
1D<8-:-@5;:? 35B1: .E @41 9-:-3191:@ @41 /;9<-:E 4-? :;@ 9-01 -:E
<>121>1:@5-8 -88;@91:@ ;> <>5B-@1 <8-/191:@ ;2 ?4->1? ;> 2A88E ;> <->@8E
/;:B1>@5.81 01.1:@A>1? 0A>5:3 @41 E1-> A:01> >1B51C //;>05:38E @41
<>;B5?5;:? ;2 /8-A?1
D5B ;2 @41 %>01> ->1 :;@ -<<85/-.81 @; @41 ;9<-:E
-:041:/1:;@/;991:@10A<;:
DB -?10 A<;: @41 -A05@ <>;/10A>1? <1>2;>910 -:0 @41 5:2;>9-@5;: -:0
1D<8-:-@5;:? 35B1: .E @41 9-:-3191:@ @41 /;9<-:E 4-? :;@ 1:@1>10 5:@;
-:E :;:/-?4 @>-:?-/@5;:? C5@4 05>1/@;>? ;> <1>?;:? /;::1/@10 C5@4 459
52 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
//;>05:38E@41<>;B5?5;:?;2/8-A?1
DB;2@41%>01>->1:;@-<<85/-.81@;
@41;9<-:E-:041:/1:;@/;991:@10A<;:
DB5 :;A>;<5:5;:@41/;9<-:E5?:;@>1=A5>10@;.1>135?@1>10A:01>?1/@5;:
;2 @41 '1?1>B1 -:7 ;2 :05- /@
-:0 -//;>05:38E @41 <>;B5?5;:? ;2
/8-A?1
DB5;2@41%>01>->1:;@-<<85/-.81@;@41;9<-:E-:041:/1:;@
/;991:@10A<;:
7:*6-76+.1*4/7/
&*<A*$:*3*;1"*<*627
1*:<.:.-,,7=6<*6<;
2:5;%.02;<:*<276"7
)
&-
&*<A* $:*3*;1"*<*62
!=5+*2 $*:<6.:
=6.
!.5+.:;128"7
("
53 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
'121>>10@;5:&->-3>-<4 A:01>F'1<;>@;:%@41>"13-8-:0'13A8-@;>E'1=A5>191:@?G?1/@5;:;2
;A>'1<;>@@;@41919.1>?;2 $1DA?(A>35/-8-:0#105/->1"595@10 ;21B1:0-@1
!*6*0.5.6<B;%.;876;2+242<A/7:6<.:6*426*6,2*476<:74;
)41 ;->0 ;2 5>1/@;>? ;2 @41 ;9<-:E 5? >1?<;:?5.81 2;> 1?@-.85?45:3 -:0 9-5:@-5:5:3 5:@1>:-8
25:-:/5-8/;:@>;8?.-?10;:@415:@1>:-8/;:@>;8;B1>25:-:/5-8>1<;>@5:3/>5@1>5-1?@-.85?410.E@41
;9<-:E/;:?501>5:3@411??1:@5-8/;9<;:1:@?;25:@1>:-8/;:@>;8?@-@105:@41A50-:/1$;@1;:
A05@;2 :@1>:-85:-:/5-8;:@>;8?%B1>5:-:/5-8'1<;>@5:35??A10.E@41 :?@5@A@1;24->@1>10
//;A:@-:@?;2 :05-)41?1>1?<;:?5.585@51?5:/8A01@4101?53:59<8191:@-@5;:-:09-5:@1:-:/1
;2-01=A-@15:@1>:-825:-:/5-8/;:@>;8?@4-@C1>1;<1>-@5:31221/@5B18E2;>1:?A>5:3@41;>01>8E-:0
1225/51:@ /;:0A/@ ;2 5@? .A?5:1?? @41 ?-213A->05:3 ;2 5@? -??1@? @41 <>1B1:@5;: -:0 01@1/@5;: ;2
2>-A0? -:0 1>>;>? @41 -//A>-/E -:0 /;9<81@1:1?? ;2 @41 -//;A:@5:3 >1/;>0? -:0 @41 @5918E
<>1<->-@5;:;2>185-.8125:-:/5-85:2;>9-@5;:-?>1=A5>10A:01> @41;9<-:51?/@
=-2<7:;B%.;876;2+242<A
%A> >1?<;:?5.585@E 5? @; 1D<>1?? -: ;<5:5;: ;: @41 5:@1>:-8 25:-:/5-8 /;:@>;8? ;B1> 25:-:/5-8
>1<;>@5:3 ;2 @41 ;9<-:E .-?10 ;: ;A> -A05@ ,1 /;:0A/@10 ;A> -A05@ 5: -//;>0-:/1 C5@4 @41
A50-:/1 $;@1 ;: A05@ ;2 :@1>:-8 5:-:/5-8 ;:@>;8? %B1> 5:-:/5-8 '1<;>@5:3 @41 HA50-:/1
$;@1I 5??A10 .E @41 :?@5@A@1 ;2 4->@1>10 //;A:@-:@? ;2 :05- -:0 @41 (@-:0->0? ;: A05@5:3
<>1?/>5.10A:01>(1/@5;:
;2@41;9<-:51?/@
@;@411D@1:@-<<85/-.81@;-:-A05@
;25:@1>:-825:-:/5-8/;:@>;8?)4;?1(@-:0->0?-:0@41A50-:/1$;@1>1=A5>1@4-@C1/;9<8EC5@4
1@45/-8 >1=A5>191:@? -:0 <8-: -:0 <1>2;>9 @41 -A05@ @; ;.@-5: >1-?;:-.81 -??A>-:/1 -.;A@
C41@41> -01=A-@1 5:@1>:-8 25:-:/5-8 /;:@>;8? ;B1> 25:-:/5-8 >1<;>@5:3 C-? 1?@-.85?410 -:0
9-5:@-5:10-:052?A/4/;:@>;8?;<1>-@101221/@5B18E5:-889-@1>5-8>1?<1/@?
%A> -A05@ 5:B;8B1? <1>2;>95:3 <>;/10A>1? @; ;.@-5: -A05@ 1B501:/1 -.;A@ @41 -01=A-/E ;2 @41
5:@1>:-8 25:-:/5-8 /;:@>;8? ?E?@19 ;B1> 25:-:/5-8 >1<;>@5:3 -:0 @415> ;<1>-@5:3 1221/@5B1:1?? %A>
-A05@;25:@1>:-825:-:/5-8/;:@>;8?;B1>25:-:/5-8>1<;>@5:35:/8A010;.@-5:5:3-:A:01>?@-:05:3;2
5:@1>:-8 25:-:/5-8 /;:@>;8? ;B1> 25:-:/5-8 >1<;>@5:3 -??1??5:3 @41 >5?7 @4-@ - 9-@1>5-8 C1-7:1??
1D5?@? -:0@1?@5:3-:01B-8A-@5:3@4101?53:-:0;<1>-@5:31221/@5B1:1??;25:@1>:-8/;:@>;8.-?10
;:@41-??1??10>5?7)41<>;/10A>1??181/@1001<1:0;:@41-A05@;>G?6A03191:@5:/8A05:3@41
-??1??91:@ ;2 @41 >5?7? ;2 9-@1>5-8 95??@-@191:@ ;2 @41 25:-:/5-8 ?@-@191:@? C41@41> 0A1 @;
2>-A0;>1>>;>
54 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
!.*62607/6<.:6*426*6,2*476<:74;#>.:26*6,2*4%.87:<260
/;9<-:EG? 5:@1>:-8 25:-:/5-8 /;:@>;8 ;B1> 25:-:/5-8 >1<;>@5:3 5? - <>;/1?? 01?53:10 @; <>;B501
>1-?;:-.81 -??A>-:/1 >13->05:3 @41 >185-.585@E ;2 25:-:/5-8 >1<;>@5:3 -:0 @41 <>1<->-@5;: ;2
25:-:/5-8 ?@-@191:@? 2;> 1D@1>:-8 <A><;?1? 5: -//;>0-:/1 C5@4 31:1>-88E -//1<@10 -//;A:@5:3
<>5:/5<81? /;9<-:EG? 5:@1>:-8 25:-:/5-8 /;:@>;8 ;B1> 25:-:/5-8 >1<;>@5:3 5:/8A01? @4;?1 <;85/51?
-:0 <>;/10A>1? @4-@ <1>@-5: @; @41 9-5:@1:-:/1 ;2 >1/;>0? @4-@ 5: >1-?;:-.81 01@-58
-//A>-@18E -:0 2-5>8E >1281/@ @41 @>-:?-/@5;:? -:0 05?<;?5@5;:? ;2 @41 -??1@? ;2 @41 /;9<-:E
<>;B501>1-?;:-.81-??A>-:/1@4-@@>-:?-/@5;:?->1>1/;>010-?:1/1??->E@;<1>95@<>1<->-@5;:
;2 25:-:/5-8 ?@-@191:@? 5: -//;>0-:/1 C5@4 31:1>-88E -//1<@10 -//;A:@5:3 <>5:/5<81? -:0 @4-@
>1/15<@? -:01D<1:05@A>1?;2@41/;9<-:E->1.15:39-01;:8E5:-//;>0-:/1C5@4-A@4;>5?-@5;:?
;2 9-:-3191:@ -:0 05>1/@;>? ;2 @41 /;9<-:E -:0
<>;B501 >1-?;:-.81 -??A>-:/1 >13->05:3
<>1B1:@5;:;>@5918E01@1/@5;:;2A:-A@4;>5?10-/=A5?5@5;:A?1;>05?<;?5@5;: ;2@41/;9<-:EG?
-??1@?@4-@/;A804-B1-9-@1>5-81221/@;:@4125:-:/5-8?@-@191:@?
61.:.6< 252<*<276;7/6<.:6*426*6,2*476<:74;#>.:26*6,2*4%.87:<260
1/-A?1;2@415:41>1:@8595@-@5;:?;25:@1>:-825:-:/5-8/;:@>;8?;B1>25:-:/5-8 >1<;>@5:35:/8A05:3
@41<;??5.585@E;2/;88A?5;:;>59<>;<1>9-:-3191:@;B1>>501;2/;:@>;8?9-@1>5-895??@-@191:@?
0A1@;1>>;>;>2>-A09-E;//A>-:0:;@.101@1/@108?;<>;61/@5;:?;2-:E1B-8A-@5;:;2@41
5:@1>:-825:-:/5-8/;:@>;8?;B1>25:-:/5-8 >1<;>@5:3@;2A@A>1<1>5;0?->1?A.61/@@;@41>5?7@4-@@41
5:@1>:-825:-:/5-8/;:@>;8;B1>25:-:/5-8>1<;>@5:39-E.1/;915:-01=A-@1.1/-A?1;2/4-:31?5:
/;:05@5;:?;>@4-@@41013>11;2/;9<85-:/1C5@4@41<;85/51?;><>;/10A>1?9-E01@1>5;>-@1
#826276
:;A>;<5:5;:@;@41.1?@;2;A>5:2;>9-@5;:-:0-//;>05:3@;@411D<8-:-@5;:?35B1:@;A?@41
;9<-:E4-?5:-889-@1>5-8>1?<1/@?-:-01=A-@15:@1>:-825:-:/5-8/;:@>;8??E?@19;B1>25:-:/5-8
>1<;>@5:3-:0?A/45:@1>:-825:-:/5-8/;:@>;8?;B1>25:-:/5-8>1<;>@5:3C1>1;<1>-@5:31221/@5B18E-?
-@ #->/4
.-?10 ;:@41 5:@1>:-8 /;:@>;8 ;B1> 25:-:/5-8 >1<;>@5:3 />5@1>5- 1?@-.85?410.E
@41 ;9<-:E /;:?501>5:3 @41 1??1:@5-8 /;9<;:1:@? ;2 5:@1>:-8 /;:@>;8 ?@-@10 5: @41 A50-:/1
$;@1 ;: A05@ ;2 :@1>:-8 5:-:/5-8 ;:@>;8? %B1> 5:-:/5-8 '1<;>@5:3 5??A10 .E @41 :?@5@A@1 ;2
4->@1>10//;A:@-:@?;2 :05-
7:*6-76+.1*4/7/
&*<A*$:*3*;1"*<*627
1*:<.:.-,,7=6<*6<;
2:5;%.02;<:*<276"7
)
&-
&*<A*$:*3*;1 "*<*62
!=5+*2 $*:<6.:
=6.
!.5+.:;128"7
("
55 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
"0A?='?<24.,6,8/!0/4.,<0 474>0/
9<70<6B589@8,="0A?=9779/4>40=,8/(0.38969240= 474>0/
,6,8.0'300>
$,<>4.?6,<= =,>!,<.3
"9>0
''('
"98?<<08>==0>=
0-.$027.* ,2$/3(.+$,2
.(2 *5-0)(,0-&0$11
,"-+$ 611$21$2
$%$00$# 611$21$2
?<<08>==0>=
(, ,"( *11$21
0 #$$"$(4 !*$1
1' ,# 1'/3(4 *$,21
- ,1 ,##4 ,"$1
2'$01
(9>,6==0>=
!$
4<7=&024=><,>498"9
*
'/
!?7-,4 !9845,39?/3,<B
?80
97:,8B'0.<0>,<B
56 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
".@=;&=:02,*4*6-!.-2,*:. 252<.-
7:5.:4A367?6*;".@=;7557-2<2.;*6-'.,1674702.; 252<.-
&<*<.5.6<7/$:7/2< 7;;
7:<1.A.*:.6-.-!*:,1
$*:<2,=4*:; "7<.
$3$,2$%/-+.$/ 1(-,0
1'$/,"-+$
'7<*46,75.
)$"&&
2/"' 0$-%01-")(,1/ #$
' ,&$0(,,3$,1-/($0
+.*-6$$!$,$%(1$5.$,0$
1'$/$5.$,0$0
'7<*4@8.6;.;
$:7/2<+./7:.@,.8<276*4<.5
5"$.1(-, *1$+
.(1 *4/(11$,-%%
$:7/2< 7;;/7:<1.8.:27-
2//$,1 5
5%-/$ /*($/6$ /0
$%$//$# 5
$:7/2< 7;;/7:<1.8.:27-
#<1.:758:.1.6;2>.6,75.
1$+01' 14(**,-1!$/$"* 00(%($#1-./-%(1-/*-00,$1-%
(,"-+$1 5
1$+01' 14(**!$/$"* 00(%($#1-./-%(1-/*-00,$1-%
(,"-+$1 5
'7<*4758:.1.6;2>.6,75./7:<1.8.:27-
*:62608.:.9=2<A;1*:.
0("
(*21$#
'$ ""-+. ,6(,&,-1$0%-/+ ,(,1$&/ *. /1-%01 ,# *-,$%(, ,"( *01 1$+$,10
!$
2:5;%.02;<:*<276"7
(
&-
!=5+*2 !7623*17=-1*:A
=6.
758*6A&.,:.<*:A
57 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
!,>;9%;8.0*(2(4+ ,+0*(8,030:,+
583,82?145=4(9!,>;95335+0:0,9(4+&,*/4525.0,9030:,+
%:(:,3,4:5-(9/25=
58:/,?,(8,4+,+ (8*/
#(8:0*;2(89
/$!-"%))%'*/$!-'%%'%/%!.
.$#!)!-/! "-*(*+!-/%)#/%1%/%!.
)*(!3%
!/.$#!)!-/! "-*(*+!-/%)#/%1%/%!.
(9/-25=-85304<,9:04.(*:0<0:0,9
(9/-25=-853-04(4*04.(*:0<0:0,9
*--*2%)#.
)/!-!./3+!).!.
!/.$#!)!-/!
.$.$!,0%1'!)/.//$!!#%))%)#*"/$!4!-
(9/*(9/,7;0<(2,4:9(::/,,4+5-:/,?,(8
$,*54*020(:0545-*(9/(4+*(9/,7;0<(2,4:9(96,8:/,*(9/-25=9:(:,3,4:
.$) .$!,0%1'!)/..+!-*1!*(+-%.!*"/$!"*''*2%)#
(8*/
(8*/
(2(4*,96,89:(:,3,4:5-*(9/-25=9
$!*(+)4%)#)*/!."*-()%)/!#-'+-/*"./) '*)!"%))%'.//!(!)/.
.+!-*0--!+*-/*"!1!) /!//$!
58(4+54),/(2-5- 58(4+54),/(2-5-:/,5(8+5-08,*:5895-
%(:?(#8(1(9/!(:(40" !,>;9%;8.0*(2(4+ ,+0*(8,030:,+
/(8:,8,+**5;4:(4: !
#
0839$,.09:8(:054!5
'
%+
;3)(0 5401(/5;+/(8?
;4,
536(4?%,*8,:(8?
58 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
"-><:&<9/1+)3)5,!-,1+)9- 141;-,
694-93?256=5):"-><:6446,1;1-:)5,'-+05636/1-: 141;-,
&;);-4-5;6.0)5/-:158<1;?
'6;)3-8<1;?);;91*<;)*3-
8<1;?&0)9-
$)9;1+<3)9: %-;)15-,)9515/: ;6-8<1;?:0)9-063,-9:6.
)71;)3
;0-+647)5?
"$(%&'!"
$!$%*$)!$&%"!,%'&'!%'
&'!%''%'(())"$))
!$$!$%) '&%')!$&'!%
%)"%#&' $(!+!$%#%') ,'
!+!$)'$(')%')!$'$!$(
)3)5+-):6.!)9+0
"$(%&'!"
$!$%*$)!$&%"!,%'&'!%'
&'!%''%'(())"$))
!$$!$%) '&%')!$&'!%
%)"%#&' $(!+!$%#%') ,'
!+!$)'$(')%')!$'$!$(
)3)5+-):6.!)9+0
!$!!$)%*$)!$&%"!!(
%#&$,!$$%)(%'#$!$)'"&')%()$"%$!$$!"())#$)(
(&'%*''&%')%+$)))
69)5,65*-0)3.6. 69)5,65*-0)3.6.;0-6)9,6.19-+;69:6.
&);?)$9)2):0");)51# "-><:&<9/1+)3)5,!-,1+)9- 141;-,
0)9;-9-,++6<5;)5; "
!$
194:%-/1:;9);165"6
(
&,
!<4*)1 !6512)06<,0)9?
<5-
647)5?&-+9-;)9?
59 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
#*#.(*$+.)0'+*
#41/ 1.%'!( *" #"'!.# ')'0#" :3'$ .,/ -8; (2 /4!+(" +(,(3$# ".,/ -8
(-".1/.1 3$# -# #.,("(+$# (- -#( -# ' 2 (32 1$&(23$1$# .%%("$ 3 ' 8 -#$1 ' -$
' 1 2'31 -#( '$".,/ -8(2+(23$#.-.,! 83."*7"' -&$
*2#*0+.'#/
'$(-5$-3.1($2 1$5 +4$# 3 +.6$1.% ".23 .1, 1*$35 +4$
4#/+**!+)#
7$7/$-2$%.13'$/$1(.#".,/1(2(-&"411$-33 7 -##$%$11$#3 7 1$(-"+4#$#(-
3'$#$3$1,(- 3(.-.%3'$-$3/1.%(3.1+.22%.13'$/$1(.#411$-33 7(2,$ 241$# 3
3'$ ,.4-3$7/$"3$#3.!$/ (#3.3'$3 7 43'.1(3($2(- "".1# -"$6(3'3'$-".,$
7"3
60 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
.+,#.05,(*0#-1',)#*0
++ 1./$138 + -3 04(/,$-3;2 1$23 3$# 3 ".23 .% "04(2(3(.- +$22 ""4,4+ 3$#
#$/1$"( 3(.- -# ""4,4+ 3$# (,/ (1,$-3 +.22$2 (% -8 (1$"3 ".232 1$ " /(3 +(9$#
4-3(+ 3'$ 22$32 1$ 1$ #8 %.1 42$ -# (-"+4#$ %1$(&'3 #43($2 3 7$2 -# $7/$-2$2
(-"(#$-3 +3. "04(2(3(.- -#(-23 ++ 3(.-
.22$2 1(2(-& %1., 3'$ 1$3(1$,$-3 .% -# & (-2 .1 +.22$2 1(2(-& %1., #(2/.2 + .%
1./$138+ -3 -#04(/,$-3 1$ 1$".&-(9$# (-3'$3 3$,$-3.%1.%(3 -#.22
#2#*1##!+%*'0'+*
$5$-4$(2,$ 241$# 33'$% (15 +4$.%3'$".-2(#$1 3(.-1$"$(5$#.11$"$(5 !+$ -#
1$".&-(9$# 6'$- (3 (2 /1.! !+$ 3' 3 3'$ $".-.,(" !$-$%(32 22."( 3$# 6(3' 3'$
31 -2 "3(.-6(++%+.63.3'$$-3(38
'**!'(*/0.1)#*0/
*'0'(#!+%*'0'+*
'$ ".,/ -8 1$".&-(9$2 %(- -"( + 22$32 %(- -"( + +( !(+(3($2 6'$- (3 !$".,$2
/ 1383.3'$".-31 "34 +/1.5(2(.-.%3'$(-2314,$-32++%(- -"( + 22$32+( !(+(3($2
1$1$".&-(9$# 3% (15 +4$.-(-(3( +1$".&-(3(.-$7"$/3%.131 #$1$"$(5 !+$26'("'
1$ (-(3( ++8 ,$ 241$# 3 31 -2 "3(.- /1("$ 1 -2 "3(.- ".23 3' 3 1$ #(1$"3+8
331(!43 !+$ 3. 3'$ "04(2(3(.-.1(224$ .% %(- -"( + 22$32 +( !(+(3($2 3' 3 1$ -.3 3
% (1 5 +4$ 3'1.4&' /1.%(3 .1 +.22 1$ ##$# 3. 3'$ % (1 5 +4$ .- (-(3( + 1$".&-(3(.-
$&4+ 16 8/41"' 2$ -#2 +$.%%(- -"( + 22$32 1$ "".4-3$#%.1 31 #$# 3$
1 /#-1#*0)#/1.#)#*0
'**!'( //#0/ 0 )+.0'6#" !+/0 (- -"( + 22$32 ' 5(-& ".-31 "34 + 3$1,2 3' 3
&(5$ 1(2$ .- 2/$"(%($# # 3$2 3. " 2' %+.62 3' 3 1$ 2.+$+8 / 8,$-32 .% /1(-"(/ + -#
(-3$1$23.-3'$/1(-"(/ +.4323 -#(-& -#3' 3 1$'$+#6(3'(- !42(-$22,.#$+6'.2$
.!)$"3(5$ (2 3. '.+# 24"' 22$32 (- .1#$1 3. ".++$"3 24"' ".-31 "34 + " 2' %+.62 1$
"+ 22(%($#(-3'(2" 3$&.184!2$04$-3+83'$2$ 1$,$ 241$# 3 ,.13(9$#".2342(-&
3'$$%%$"3(5$(-3$1$23,$3'.#+$22 -8(,/ (1,$-3+.22$2
),(+5## #*#$'0/
'$.,/ -8%.++.623'$/.+("8.% "".4-3(-&%.13'$2 ,$.-+8.-"1823 ++(9 3(.-.%
3'$+( !(+(38
.*'*%/#.&.#
2(" 1-(-&2/$12' 1$(2".,/43$#!8#(5(#(-&3'$-$3/1.%(3 331(!43 !+$3.$04(38
2' 1$'.+#$12 !8 3'$ 6$(&'3$# 5$1 &$ -4,!$1 .% $04(38 2' 1$2 .4323 -#(-& #41(-&
3'$/$1(.#
61 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
#/#/
+('!5,,('! (#$.+),.'(
'$ .,/ -8 "".4-32 %.1 $ "' +$ 2$ ".,/.-$-3 6(3'(- 3'$ ".-31 "3 2 +$ 2$
2$/ 1 3$+8 %1., -.-+$ 2$ ".,/.-$-32 .% 3'$ ".-31 "3 -# ++." 3$2 3'$
".-2(#$1 3(.- (- 3'$ ".-31 "3 3. $ "' +$ 2$ ".,/.-$-3 .- 3'$ ! 2(2 .% 3'$ 1$+ 3(5$
23 -# +.-$/1("$.%3'$+$ 2$".,/.-$-3 -#3'$ &&1$& 3$23 -# +.-$/1("$.%3'$
-.-+$ 2$".,/.-$-32
'$ .,/ -8 1$".&-(2$2 1(&'3.%42$ 22$3 1$/1$2$-3(-& (32 1(&'3 3. 42$ 3'$
4-#$1+8(-& 22$3%.13'$+$ 2$3$1, 33'$+$ 2$".,,$-"$,$-3# 3$'$".23.%3'$
1(&'3.%42$ 22$3,$ 241$# 3(-"$/3(.-2' ++".,/1(2$.%3'$ ,.4-3.%3'$(-(3( +
,$ 241$,$-3 .% 3'$ +$ 2$ +( !(+(38 #)423$# %.1 -8 +$ 2$ / 8,$-32 , #$ 3 .1
!$%.1$ 3'$ ".,,$-"$,$-3 # 3$ +$22 -8 +$ 2$ (-"$-3(5$2 1$"$(5$# /+42 -8 (-(3( +
#(1$"3 ".232 (-"411$# -# - $23(, 3$ .% ".232 3. !$ (-"411$# !8 3'$ +$22$$ (-
#(2, -3+(-& -#1$,.5(-&3'$4-#$1+8(-& 22$3.11$23.1(-&3'$4-#$1+8(-& 22$3.1
2(3$.-6'("'(3(2+." 3$#'$1(&'3.%42$ 22$32(224!2$04$-3+8,$ 241$# 3".23
+$22 -8 ""4,4+ 3$# #$/1$"( 3(.- ""4,4+ 3$# (,/ (1,$-3 +.22$2 (% -8 -#
#)423$# %.1 -8 1$,$ 241$,$-3 .% 3'$ +$ 2$ +( !(+(38 '$ 1(&'3.%42$ 22$32 (2
#$/1$"( 3$# 42(-& 3'$ 231 (&'3+(-$,$3'.# %1., 3'$ ".,,$-"$,$-3 # 3$.5$1 3'$
2'.13$1.%+$ 2$3$1,.142$%4++(%$.%1(&'3.%42$ 22$3'$$23(, 3$#42$%4++(5$2.%
1(&'3.%42$ 22$32 1$#$3$1,(-$#.-3'$2 ,$! 2(2 23'.2$.%/1./$138/+ -3 -#
$04(/,$-3 (&'3.%42$ 22$32 1$ 3$23$# %.1 (,/ (1,$-3 6'$-$5$1 3'$1$ (2 -8
(-#(" 3(.- 3' 3 3'$(1" 118(-& ,.4-32 , 8 -.3 !$ 1$".5$1 !+$ ,/ (1,$-3 +.22(%
-8(21$".&-(2$#(-3'$23 3$,$-3.%/1.%(3 -#+.22
62 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
1$ 22$22,$-3 .1 +$ 2$ ,.#(%(" 3(.-2 .1 3. 1$%+$"3 1$5(2$# (- 24!23 -"$ %(7$# +$ 2$
/ 8,$-32 '$ ".,/ -8 1$".&-(2$2 3'$ ,.4-3 .% 3'$ 1$,$ 241$,$-3 .% +$ 2$
+( !(+(38#4$3.,.#(%(" 3(.- 2 - #)423,$-33.3'$1(&'3.%42$ 22$3 -#23 3$,$-3
.% /1.%(3 -# +.22 #$/$-#(-& 4/.- 3'$ - 341$ .% ,.#(%(" 3(.- '$1$ 3'$ " 118(-&
,.4-3.%3'$1(&'3.%42$ 22$3(21$#4"$#3.9$1. -#3'$1$(2 %413'$11$#4"3(.-
(- 3'$ ,$ 241$,$-3 .% 3'$ +$ 2$ +( !(+(38 3'$ .,/ -8 1$".&-(2$2 -8 1$, (-(-&
,.4-3.%3'$ 1$ ,$ 241$,$-3(-23 3$,$-3.%/1.%(3 -#+.22
63 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
/,*,)!#%!)!$!+
&)$)#0"%&.%*/,*&$$&!+!*% %&#&!*!$!+
&+*+&+%#&%!%%!#++$%+*
&+)&')+0'#%+(,!'$%+
)+!,#)* ,)%!+,)!/+,)* &+#
!! %$#!
"!
"!
!! %$#!
))0!%-#,*&)
))0!%-#,*&)
64 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
%63130')#!+!-$%$)#!0%),)2%$
.0,%0+7*-.5-!1%631.,,.$)2)%1!-$ %#(-.+.')%1),)2%$
.2%12.2!-$!+.-%)-!-#)!+2!2%,%-21
1!2!0#(
!02)#3+!01
.2% -#.,% !611%21%2
%&$-))*)
.2%
%&%00%$ !611%2%2
((-))*
.2% 0!$%%#%)4!"+%1
+(&%)!(&&
* ()
+*)*%!%&('(!&-!%)!-$&%* )
* ()
.2%!1(!-$!1(/3)4!+%-21
#%,!* %")
) &%%
.2%.!-1!-$$4!-#%1
%*(&('&(*&%
.2%2(%01
'&)!*)
* (+((%*))*)
65 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
);86#85+-'%/%1()(-'%5)-0-7)(
250)5/<.12:1%6);862002(-7-)6%1($)',12/2+-)6-0-7)(
27)672#7%1(%/21)-1%1'-%/#7%7)0)176
"-1
!%57-'8/%56 6%7
6%7
22*#,%5)6 02817 22*#,%5)6 02817
27)48-7<#,%5)%3-7%/
87,25-=)(#,%5)%3-7%/
37,6:"+$4(51)!5
($&+
668)(%1(#8&6'5-&)(%1(*8//<3%-(83
37,6:5+$4(51)!5
($&+)7..:2$,'72
")'21'-/-%7-212*180&)52*6,%5)6
7656$0',0*7/%(41)5+$4(5$66+(%(*,00,0*1)6+(:($4
''"+$4(5,557(''74,0*6+(:($4
7656$0',0*7/%(41)5+$4(5$66+((0'1)6+(:($4
$)506"-+,76%77%',)(72)48-7<6,%5)6
#+(1/2$0:+$510.:10(&.$551)(37,6:5+$4(+$8,0*2$48$.7(1)!52(45+$4(
$&++1.'(41)(37,6:5+$4(,5(06,6.('6110(816(2(45+$4(+(.'
..6+((37,6:5+$4(54$0-2$4,2$557,0$..4(52(&65,0&.7',0*%76016.,/,6('61(06,6.(/(06)14',8,'(0'%1075,557($0'4,*+65,557(
06+((8(061)
.,37,'$6,106+((37,6:5+$4(+1.'(45$4((.,*,%.(614(&(,8(6+(4(/$,0,0*$55(651)6+(1/2$0:$)6(4',564,%76,101)$...,$%,.,6,(5,02412146,10616+(,4
5+$4(+1.',0*
)7%-/62(6,%5),2/()56,2/(-1+025)7,%16,%5)6%6%7<)%5)1(
6%7%5',
6%7%5',
%0)2*#,%5),2/()56
2
2*#,%5)6 ,2/(-1+ 2
2*#,%5)6 ,2/(-1+
,.'4('(4&$06,.( 866'
"+:$/.&1+1.+(/,&$.56'
")'21'-/-%7-212*180&)52*6,%5)628767%1(-1+%1(%02817%77,)&)+-11-1+%1(%77,))1(2*7,)<)%5
6%7
6%7
!%57-'8/%56
22*#,%5)6 02817 22*#,%5)6 02817
48-7<#,%5)62*3%59%/8)"6
*8//<3%-(83
7656$0',0*$66+(%(*,00,0*1)6+(:($4
''557(''74,0*6+(:($4
8767%1(-1+%77,))1(2*7,)<)%5
7,)5()7%-/62*)48-7<6,%5)6*25%3)5-2(2**-9)<)%56-00)(-%7)/<35)')(-1+%5',
!%57-'8/%56
**4(*$6(07/%(41)5+$4($..166('$5)7..:2$,'7227457$0661&1064$&659,6+1762$:/(06
**4(*$6(07/%(41)5+$4(5$..166('$5)7..:2$,'%10755+$4(5
**4(*$6(07/%(41)5+$4(5%17*+6%$&-
66 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
#20.0-$&!(*"#"&!-#&)&/#"
+-)#-(3'*+1*.#20.+))+"&/&#.*"#!%*+(+$&#.&)&/#"
+/#./+/*"(+*#&**!&(//#)#*/.
&*
-/&!0(-. ./-!%
+/#/%#-,0&/3
#/&*#"-*&*$.
*!(%(#&(!
+)"%-),,")+-$!/!+
&),%(#&(!
+/#-"#3 (#.
.!-)%+)'&&( ! %.'(-!+*+%,!,
-$!+,
+/#/%#-0--#*/& &(&/&#.
--.-)+/.!,
67 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
"->;9&;8/1+)3)5,!-,1+)8- 141:-,
684-83?256=5)9"->;96446,1:1-9)5,'-+05636/1-9 141:-,
"6:-9:6&:)5,)365-15)5+1)3&:):-4-5:9
$)8:1+;3)89 68:0-?-)8-5,-,!)8+0
"6:-
%-<-5;-.864#7-8):1659
'*4.;*6-'.:>2,.;
"6:-
#:0-85+64-9
$<1.:6,75.
"6:-
69:6.!):-81)3659;4-,
%=:,1*;.;
"6:-
0)5/-9155<-5:681-9
$8.6260'<7,326(:*-.
47;260'<7,326(:*-.
"6:-
4736?--*-5-.1:->7-59-
'*4*:A
'<*//).4/*:.@8.6;.;
"6:-
-78-+1):165->7-59-9
.8:.,2*<276
"6:-
#:0-8->7-59-9
%*A5.6<<7<1.=-2<7:;
%:26<260*6-'<*<276*:A
76>.A*6,.*6-(:*>.44260@8.6;.;
*631*:0.;
'1*:.&.02;<:*:*6-.87;2<7:A..;
!2;<260..;
%:7/.;;276*4..;
:73.:*0.7552;;276@8.6;.;
&.6<&*<.;*6-(*@.;
*--.+<;
.6.:*4$//2,.@8.6;.;
"6:-
$)?4-5::6;,1:689
=-2<..;
"6:- )8515/$-8&0)8-
(7<*4758:.1.6;2>.6,75./7:<1.8.:27-
).201<.->.:*0.#=5+.:7/9=2<A'1*:.;
*;2,24=<.-*:6260%.:'1*:.
68 of 69
Annual Report 2020-21 Nexus Surgical and Medicare Limited
"6:-
&-/4-5:%-768:15/
(1.758*6A2;.60*0.-5*264A26<:*-260*,<2>2<2.;*6-*;;=,1<1.:.*:.677<1.::.87:<*+4.;.05.6<*;-./26.-
+A6-2*6,,7=6<260'<*6-*:-76$8.:*<260'.05.6<;2;;=.-+A<1.6;<2<=<.7/1*:<.:.-,,7=6<*6<;7/
6-2*
"6:-;-9:641+8694)33-5:-87819-9
(1.758*6A1*;,*44.-/7:,7584.<.26/7:5*<276/:75*44<1.>.6-7:;:.0*:-260<1.2:;<*<=;*;;5*44;,*4.
52,:7
26-=;<:2*4=6-.:<*3260 *;.-7626/7:5*<276:.,.2>.-:.0*:-260<1.;<*<=;7/<1.>.6-7:;<1.:.*:.67*57=6<;
7=<;<*6-260/7:57:.<1*6&;
/7:57:.<1*6-*A;
"6:-%-3):-,$)8:?19+369;8-
*!2;<7/&.4*<.-%*:<2.;?2<1?175<:*6;*,<276;1*>.<*3.684*,.*6-&.4*<276;128
-?!)5)/-4-5:$-89655-3)5,:0-188-3):1<-9
")4- %-3):165
&=8.;1&7760<* @.,=<2>.2:.,<7:
&*;?*:778 7;12 @.,=<2>.2:.,<7:
"7623*17=-1*:A 758*6A'.,:.<*:A
+6<.:8:2;.7>.:?12,13.A5*6*0.:2*48.:;766.4*6-:.4*<2>.;7/;=,18.:;766.4*:.*+4.<7.@.:,2;.'2062/2,*6<
26/4=.6,.
'=5*60*47557-2<2.;%><!<-
&.4*<.-%*:<A(:*6;*,<276; #&26
-?!)5)/-81)3
"):;8-6.'8)59)+:165 $-89655-3 #:0-89 '6:)3
%-3):1<-
5847A5.6<+.6./2<.@8.6;.;
&=8.;1&7760<*
&*5'?*:778 7;12
"7623*17=-1*:A
"6:-
(1.8:.>27=;A.*:/20=:.;1*>.+..6:.0:7=8.-
:.*::*60.-?1.:.>.:/7=6-6.,.;;*:A
68)5,65*-0)3.6.:0-6)8,6.18-+:6896.
"->;9&;8/1+)3)5,!-,1+)8- 141:-,
"
!
$
!;4*)1
;5-
69 of 69